| Year |
Citation |
Score |
| 2023 |
Anmella G, Meehan A, Ashton M, Mohebbi M, Fico G, Ng CH, Maes M, Berk L, De Prisco M, Singh AB, Malhi GS, Berk M, Dodd S, Hidalgo-Mazzei D, Grande I, et al. Exploring Clinical Subgroups of Participants with Major Depressive Disorder that may Benefit from Adjunctive Minocycline Treatment. Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology. 22: 33-44. PMID 38247410 DOI: 10.9758/cpn.23.1098 |
0.363 |
|
| 2023 |
Sarmiento A, Dean OM, Kavanagh BE, Mohebbi M, Berk M, Dodd S, Cotton SM, Malhi GS, Ng CH, Turner A. The Influence of Personality Disorder Symptoms on Treatment Outcomes in Bipolar Disorder: A Secondary Analysis of a Randomised Controlled Trial. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 7067437231213558. PMID 37964558 DOI: 10.1177/07067437231213558 |
0.344 |
|
| 2023 |
Schwartz OS, Amminger P, Baune BT, Bedi G, Berk M, Cotton SM, Daglas-Georgiou R, Glozier N, Harrison B, Hermens DF, Jennings E, Lagopoulos J, Loo C, Mallawaarachchi S, Martin D, et al. The Study of Ketamine for Youth Depression (SKY-D): study protocol for a randomised controlled trial of low-dose ketamine for young people with major depressive disorder. Trials. 24: 686. PMID 37875938 DOI: 10.1186/s13063-023-07631-3 |
0.33 |
|
| 2023 |
McIntyre RS, Alsuwaidan M, Baune BT, Berk M, Demyttenaere K, Goldberg JF, Gorwood P, Ho R, Kasper S, Kennedy SH, Ly-Uson J, Mansur RB, McAllister-Williams RH, Murrough JW, Nemeroff CB, et al. Treatment-resistant depression: definition, prevalence, detection, management, and investigational interventions. World Psychiatry : Official Journal of the World Psychiatric Association (Wpa). 22: 394-412. PMID 37713549 DOI: 10.1002/wps.21120 |
0.306 |
|
| 2023 |
Marx W, Penninx BWJH, Solmi M, Furukawa TA, Firth J, Carvalho AF, Berk M. Major depressive disorder. Nature Reviews. Disease Primers. 9: 44. PMID 37620370 DOI: 10.1038/s41572-023-00454-1 |
0.357 |
|
| 2023 |
Russell SE, Wrobel AL, Ashton MM, Turner A, Mohebbi M, Berk M, Cotton S, Dodd S, Ng CH, Malhi GS, Dean OM. Does Post-traumatic Stress Disorder Impact Treatment Outcomes within a Randomised Controlled Trial of Mitochondrial Agents for Bipolar Depression? Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology. 21: 457-465. PMID 37424414 DOI: 10.9758/cpn.22.981 |
0.323 |
|
| 2023 |
Khanra S, Reddy P, Giménez-Palomo A, Park CHJ, Panizzutti B, McCallum M, Arumugham SS, Umesh S, Debnath M, Das B, Venkatasubramanian G, Ashton M, Turner A, Dean OM, Walder K, ... ... Berk M, et al. Metabolic regulation to treat bipolar depression: mechanisms and targeting by trimetazidine. Molecular Psychiatry. PMID 37386057 DOI: 10.1038/s41380-023-02134-8 |
0.372 |
|
| 2023 |
Russell SE, Skvarc DR, Mohebbi M, Camfield D, Byrne LK, Turner A, Ashton MM, Berk M, Dodd S, Malhi GS, Cotton SM, Bush AI, Dean OM. The Impact of -acetylcysteine on Major Depression: Qualitative Observation and Mixed Methods Analysis of Participant Change during a 12-week Randomised Controlled Trial. Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology. 21: 320-331. PMID 37119225 DOI: 10.9758/cpn.2023.21.2.320 |
0.344 |
|
| 2023 |
Wrobel AL, Russell SE, Jayasinghe A, Lotfaliany M, Turner A, Dean OM, Cotton SM, Diaz-Byrd C, Yocum AK, Duval ER, Ehrlich TJ, Marshall DF, Berk M, McInnis MG. Interpersonal Trauma and Depression Severity Among Individuals With Bipolar Disorder: Findings From the Prechter Longitudinal Study of Bipolar Disorder. The Journal of Clinical Psychiatry. 84. PMID 37058607 DOI: 10.4088/JCP.22m14434 |
0.301 |
|
| 2023 |
Panizzutti B, Skvarc D, Lin S, Croce S, Meehan A, Bortolasci CC, Marx W, Walker AJ, Hasebe K, Kavanagh BE, Morris MJ, Mohebbi M, Turner A, Gray L, Berk L, ... ... Berk M, et al. Minocycline as Treatment for Psychiatric and Neurological Conditions: A Systematic Review and Meta-Analysis. International Journal of Molecular Sciences. 24. PMID 36982324 DOI: 10.3390/ijms24065250 |
0.307 |
|
| 2023 |
Wrobel AL, Cotton SM, Jayasinghe A, Diaz-Byrd C, Yocum AK, Turner A, Dean OM, Russell SE, Duval ER, Ehrlich TJ, Marshall DF, Berk M, McInnis MG. Childhood trauma and depressive symptoms in bipolar disorder: a network analysis. Acta Psychiatrica Scandinavica. PMID 36645036 DOI: 10.1111/acps.13528 |
0.319 |
|
| 2023 |
Dragioti E, Radua J, Solmi M, Gosling CJ, Oliver D, Lascialfari F, Ahmed M, Cortese S, Estradé A, Arrondo G, Gouva M, Fornaro M, Batiridou A, Dimou K, Tsartsalis D, ... ... Berk M, et al. Impact of mental disorders on clinical outcomes of physical diseases: an umbrella review assessing population attributable fraction and generalized impact fraction. World Psychiatry : Official Journal of the World Psychiatric Association (Wpa). 22: 86-104. PMID 36640414 DOI: 10.1002/wps.21068 |
0.306 |
|
| 2023 |
Green JE, Berk M, Mohebbi M, Loughman A, McGuinness AJ, Castle D, Chatterton ML, Perez J, Strandwitz P, Athan E, Hair C, Nierenberg AA, Cryan JF, Jacka F. Feasibility, Acceptability, and Safety of Faecal Microbiota Transplantation in the Treatment of Major Depressive Disorder: A Pilot Randomized Controlled Trial. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 7067437221150508. PMID 36637229 DOI: 10.1177/07067437221150508 |
0.336 |
|
| 2023 |
Moller CI, Badcock PB, Hetrick SE, Rice S, Berk M, Witt K, Chanen AM, Dean OM, Gao C, Cotton SM, Davey CG. Predictors of suicidal ideation severity among treatment-seeking young people with major depressive disorder: The role of state and trait anxiety. The Australian and New Zealand Journal of Psychiatry. 48674221144262. PMID 36629043 DOI: 10.1177/00048674221144262 |
0.316 |
|
| 2023 |
Green JE, McGuinness AJ, Berk M, Castle D, Athan E, Hair C, Strandwitz P, Loughman A, Nierenberg AA, Cryan JF, Mohebbi M, Jacka F. Safety and feasibility of faecal microbiota transplant for major depressive disorder: study protocol for a pilot randomised controlled trial. Pilot and Feasibility Studies. 9: 5. PMID 36624505 DOI: 10.1186/s40814-023-01235-z |
0.339 |
|
| 2022 |
Walker AJ, Mohebbi M, Maes M, Berk M, Walder K, Bortolasci CC, Liu ZS, Ng CH, Ashton MM, Berk L, Singh AB, Malhi GS, Dean OM. Adjunctive minocycline for major depressive disorder: A sub-study exploring peripheral immune-inflammatory markers and associated treatment response. Brain, Behavior, & Immunity - Health. 27: 100581. PMID 36632339 DOI: 10.1016/j.bbih.2022.100581 |
0.374 |
|
| 2022 |
McIntyre RS, Alda M, Baldessarini RJ, Bauer M, Berk M, Correll CU, Fagiolini A, Fountoulakis K, Frye MA, Grunze H, Kessing LV, Miklowitz DJ, Parker G, Post RM, Swann AC, et al. The clinical characterization of the adult patient with bipolar disorder aimed at personalization of management. World Psychiatry : Official Journal of the World Psychiatric Association (Wpa). 21: 364-387. PMID 36073706 DOI: 10.1002/wps.20997 |
0.327 |
|
| 2022 |
Wrobel AL, Russell SE, Jayasinghe A, Kavanagh BE, Lotfaliany M, Turner A, Dean OM, Cotton SM, Diaz-Byrd C, Yocum AK, Duval ER, Ehrlich TJ, Marshall DF, Berk M, McInnis MG. Personality traits as mediators of the relationship between childhood trauma and depression severity in bipolar disorder: A structural equation model. The Australian and New Zealand Journal of Psychiatry. 48674221115644. PMID 35924739 DOI: 10.1177/00048674221115644 |
0.314 |
|
| 2022 |
Gabriel FC, Oliveira M, Martella BM, Berk M, Brietzke E, Jacka FN, Lafer B. Nutrition and bipolar disorder: a systematic review. Nutritional Neuroscience. 1-15. PMID 35608150 DOI: 10.1080/1028415X.2022.2077031 |
0.35 |
|
| 2022 |
Russell SE, Wrobel AL, Dean OM, Berk M, Dodd S, Ng CH, Malhi GS, Cotton SM, Sarris J, Turner A. Mixed Methods Thematic Analysis of a Randomised Controlled Trial of Adjunctive Mitochondrial Agents for Bipolar Depression. Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology. 20: 300-310. PMID 35466101 DOI: 10.9758/cpn.2022.20.2.300 |
0.307 |
|
| 2022 |
Young LM, Moylan S, John T, Turner M, Opie R, Hockey M, Saunders D, Bruscella C, Jacka F, Teychenne M, Rosenbaum S, Banker K, Mahoney S, Tembo M, Lai J, ... ... Berk M, et al. Evaluating telehealth lifestyle therapy versus telehealth psychotherapy for reducing depression in adults with COVID-19 related distress: the curbing anxiety and depression using lifestyle medicine (CALM) randomised non-inferiority trial protocol. Bmc Psychiatry. 22: 219. PMID 35346115 DOI: 10.1186/s12888-022-03840-3 |
0.306 |
|
| 2022 |
Bradlow RCJ, Berk M, Kalivas PW, Back SE, Kanaan RA. The Potential of N-Acetyl-L-Cysteine (NAC) in the Treatment of Psychiatric Disorders. Cns Drugs. PMID 35316513 DOI: 10.1007/s40263-022-00907-3 |
0.358 |
|
| 2022 |
Sarris J, Ravindran A, Yatham LN, Marx W, Rucklidge JJ, McIntyre RS, Akhondzadeh S, Benedetti F, Caneo C, Cramer H, Cribb L, de Manincor M, Dean O, Deslandes AC, Freeman MP, ... ... Berk M, et al. Clinician guidelines for the treatment of psychiatric disorders with nutraceuticals and phytoceuticals: The World Federation of Societies of Biological Psychiatry (WFSBP) and Canadian Network for Mood and Anxiety Treatments (CANMAT) Taskforce. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 1-32. PMID 35311615 DOI: 10.1080/15622975.2021.2013041 |
0.306 |
|
| 2022 |
McInnis MG, Andreassen OA, Andreazza AC, Alon U, Berk M, Brister T, Burdick KE, Cui D, Frye M, Leboyer M, Mitchell PB, Merikangas K, Nierenberg AA, Nurnberger JI, Pham D, et al. Strategies and foundations for scientific discovery in longitudinal studies of bipolar disorder. Bipolar Disorders. PMID 35244317 DOI: 10.1111/bdi.13198 |
0.303 |
|
| 2022 |
Wrobel AL, Russell SE, Jayasinghe A, Lotfaliany M, Turner A, Dean OM, Cotton SM, Diaz-Byrd C, Yocum AK, Duval ER, Ehrlich TJ, Marshall DF, Berk M, McInnis MG. Attachment insecurity partially mediates the relationship between childhood trauma and depression severity in bipolar disorder. Acta Psychiatrica Scandinavica. PMID 35243610 DOI: 10.1111/acps.13419 |
0.346 |
|
| 2021 |
Herniman SE, Wood SJ, Cotton SM, Allott KA, Davey C, Berk M, Phillips LJ. The specific phenotype of depression in recent onset schizophrenia spectrum disorders: A symptom profile and network comparison to recent onset major depressive disorder without psychotic features. Schizophrenia Research. 240: 52-60. PMID 34942537 DOI: 10.1016/j.schres.2021.11.048 |
0.32 |
|
| 2021 |
Hasebe K, Mohebbi M, Gray L, Walker AJ, Bortolasci CC, Turner A, Berk M, Walder K, Maes M, Kanchanatawan B, Ashton MM, Berk L, Ng CH, Malhi GS, Singh AB, et al. Exploring interleukin-6, lipopolysaccharide binding protein and brain-derived neurotrophic factor following 12 weeks of adjunctive minocycline treatment for depression. Acta Neuropsychiatrica. 1-24. PMID 34937590 DOI: 10.1017/neu.2021.44 |
0.32 |
|
| 2021 |
Fornaro M, Carvalho AF, De Prisco M, Mondin AM, Billeci M, Selby P, Iasevoli F, Berk M, Castle DJ, de Bartolomeis A. The prevalence, odds, predictors, and management of tobacco use disorder or nicotine dependence among people with severe mental illness: Systematic review and meta-analysis. Neuroscience and Biobehavioral Reviews. 132: 289-303. PMID 34838527 DOI: 10.1016/j.neubiorev.2021.11.039 |
0.309 |
|
| 2021 |
Yatham LN, Chakrabarty T, Bond DJ, Schaffer A, Beaulieu S, Parikh SV, McIntyre RS, Milev RV, Alda M, Vasquez G, Ravindran AV, Frey BN, Sharma V, Goldstein BI, Rej S, ... ... Berk M, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) recommendations for the management of patients with bipolar disorder with mixed presentations. Bipolar Disorders. PMID 34599629 DOI: 10.1111/bdi.13135 |
0.311 |
|
| 2021 |
Martins LB, Braga Tibães JR, Berk M, Teixeira AL. Diabetes and mood disorders: shared mechanisms and therapeutic opportunities. International Journal of Psychiatry in Clinical Practice. 1-13. PMID 34348557 DOI: 10.1080/13651501.2021.1957117 |
0.302 |
|
| 2021 |
Walker AJ, Kim Y, Borissiouk I, Rehder R, Dodd S, Morris G, Nierenberg AA, Maes M, Fernandes BS, Dean OM, Williams LJ, A Eyre H, Kim SW, Zoungas S, Carvalho AF, ... Berk M, et al. Statins: Neurobiological underpinnings and mechanisms in mood disorders. Neuroscience and Biobehavioral Reviews. PMID 34265321 DOI: 10.1016/j.neubiorev.2021.07.012 |
0.346 |
|
| 2021 |
Morris G, Gamage E, Travica N, Berk M, Jacka F, O'Neil A, Puri BK, Carvalho AF, Bortolasci CC, Walder K, Marx W. Polyphenols as adjunctive treatments in psychiatric and neurodegenerative disorders: efficacy, mechanisms of action, and factors influencing inter-individual response. Free Radical Biology & Medicine. PMID 34062263 DOI: 10.1016/j.freeradbiomed.2021.05.036 |
0.307 |
|
| 2021 |
Forbes MP, O'Neil A, Lane M, Agustini B, Myles N, Berk M. Major Depressive Disorder in Older Patients as an Inflammatory Disorder: Implications for the Pharmacological Management of Geriatric Depression. Drugs & Aging. PMID 33913114 DOI: 10.1007/s40266-021-00858-2 |
0.328 |
|
| 2021 |
Chen JX, Yin L, Xu HT, Zhang SY, Huang WQ, Li HJ, Li BB, Yang KB, Li Q, Berk M, Su YA. Psychometric Properties of the Chinese Version of the Bipolar Depression Rating Scale for Bipolar Disorder. Neuropsychiatric Disease and Treatment. 17: 787-795. PMID 33737809 DOI: 10.2147/NDT.S300761 |
0.349 |
|
| 2021 |
McIntyre RS, Rosenblat JD, Nemeroff CB, Sanacora G, Murrough JW, Berk M, Brietzke E, Dodd S, Gorwood P, Ho R, Iosifescu DV, Lopez Jaramillo C, Kasper S, Kratiuk K, Lee JG, et al. Synthesizing the Evidence for Ketamine and Esketamine in Treatment-Resistant Depression: An International Expert Opinion on the Available Evidence and Implementation. The American Journal of Psychiatry. appiajp202020081251. PMID 33726522 DOI: 10.1176/appi.ajp.2020.20081251 |
0.337 |
|
| 2021 |
Forbes M, Berk M, Reynolds C. Major depressive disorders and bipolar disorders in older adults: Commentary on the RANCZP mood disorders guideline summaries. Bipolar Disorders. PMID 33638272 DOI: 10.1111/bdi.13068 |
0.309 |
|
| 2020 |
Dodd S, Bauer M, Carvalho AF, Eyre H, Fava M, Kasper S, Kennedy SH, Khoo JP, Lopez Jaramillo C, Malhi GS, McIntyre RS, Mitchell PB, Castro AMP, Ratheesh A, Severus E, ... ... Berk M, et al. A clinical approach to treatment resistance in depressed patients: What to do when the usual treatments don't work well enough? The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 1-20. PMID 33289425 DOI: 10.1080/15622975.2020.1851052 |
0.324 |
|
| 2020 |
McIntyre RS, Berk M, Brietzke E, Goldstein BI, López-Jaramillo C, Kessing LV, Malhi GS, Nierenberg AA, Rosenblat JD, Majeed A, Vieta E, Vinberg M, Young AH, Mansur RB. Bipolar disorders. Lancet (London, England). 396: 1841-1856. PMID 33278937 DOI: 10.1016/S0140-6736(20)31544-0 |
0.352 |
|
| 2020 |
Zazula R, Husain MI, Mohebbi M, Walker AJ, Chaudhry IB, Khoso AB, Ashton MM, Agustini B, Husain N, Deakin J, Young AH, Berk M, Kanchanatawan B, Ng CH, Maes M, et al. Minocycline as adjunctive treatment for major depressive disorder: Pooled data from two randomized controlled trials. The Australian and New Zealand Journal of Psychiatry. 4867420965697. PMID 33092404 DOI: 10.1177/0004867420965697 |
0.35 |
|
| 2020 |
Sunder P, Chia MF, Filia K, Macneil C, Hasty M, Davey C, McGorry P, Berk M, Cotton S, Ratheesh A. Does guideline-concordant care predict naturalistic outcomes in youth with early stage bipolar I disorder? Journal of Affective Disorders. 278: 23-32. PMID 32949870 DOI: 10.1016/J.Jad.2020.09.037 |
0.305 |
|
| 2020 |
Medvedev ON, Berk M, Dean OM, Brown E, Sandham MH, Dipnall JF, McNamara RK, Sumich A, Krägeloh CU, Narayanan A, Siegert RJ. A Novel Way to Quantify Schizophrenia Symptoms in Clinical Trials. European Journal of Clinical Investigation. e13398. PMID 32894576 DOI: 10.1111/Eci.13398 |
0.301 |
|
| 2020 |
Kessing LV, Rytgaard HC, Ekstrøm CT, Torp-Pedersen C, Berk M, Gerds TA. Antihypertensive Drugs and Risk of Depression: A Nationwide Population-Based Study. Hypertension (Dallas, Tex. : 1979). HYPERTENSIONAHA12015. PMID 32829669 DOI: 10.1161/Hypertensionaha.120.15605 |
0.398 |
|
| 2020 |
Maier A, Dharan A, Oliver G, Berk M, Redston S, Back SE, Kalivas P, Ng C, Kanaan RA. A multi-centre, double-blind, 12-week, randomized, placebo-controlled trial to assess the efficacy of adjunctive N-Acetylcysteine for treatment-resistant PTSD: a study protocol. Bmc Psychiatry. 20: 397. PMID 32762663 DOI: 10.1186/S12888-020-02793-9 |
0.316 |
|
| 2020 |
Fornaro M, Carvalho AF, Fusco A, Anastasia A, Solmi M, Berk M, Sim K, Vieta E, de Bartolomeis A. The concept and management of acute episodes of treatment-resistant bipolar disorder: a systematic review and exploratory meta-analysis of randomized controlled trials. Journal of Affective Disorders. 276: 970-983. PMID 32750614 DOI: 10.1016/J.Jad.2020.07.109 |
0.375 |
|
| 2020 |
Kavanagh BE, Stuart AL, Berk M, Turner A, Dean OM, Pasco JA, Jackson HJ, Koivumaa-Honkanen H, Chanen AM, Williams LJ. Personality disorder increases risk of low quality of life among women with mental state disorders. Comprehensive Psychiatry. 102: 152193. PMID 32730960 DOI: 10.1016/J.Comppsych.2020.152193 |
0.354 |
|
| 2020 |
Ching CRK, Hibar DP, Gurholt TP, Nunes A, Thomopoulos SI, Abé C, Agartz I, Brouwer RM, Cannon DM, de Zwarte SMC, Eyler LT, Favre P, Hajek T, Haukvik UK, Houenou J, ... ... Berk M, et al. What we learn about bipolar disorder from large-scale neuroimaging: Findings and future directions from the ENIGMA Bipolar Disorder Working Group. Human Brain Mapping. PMID 32725849 DOI: 10.1002/Hbm.25098 |
0.384 |
|
| 2020 |
Malhi GS, Bell E, Outhred T, Berk M. Lithium therapy and its interactions. Australian Prescriber. 43: 91-93. PMID 32675910 DOI: 10.18773/Austprescr.2020.024 |
0.302 |
|
| 2020 |
Guu TW, Mischoulon D, Sarris J, Hibbeln J, McNamara RK, Hamazaki K, Freeman MP, Maes M, Matsuoka YJ, Belmaker RH, Marx W, Pariante C, Berk M, Jacka F, Su KP. Corrigendum to "A multi-national, multi-disciplinary Delphi consensus study on using omega-3 polyunsaturated fatty acids (n-3 PUFAs) for the treatment of major depressive disorder". [J Affect Disord. 15 (2020) 233-238]. Journal of Affective Disorders. 274: 1226-1227. PMID 32663964 DOI: 10.1016/J.Jad.2020.06.007 |
0.417 |
|
| 2020 |
Tremain H, Fletcher K, Scott J, McEnery C, Berk M, Murray G. The influence of stage of illness on functional outcomes after psychological treatment in bipolar disorder: A systematic review. Bipolar Disorders. PMID 32621794 DOI: 10.1111/Bdi.12974 |
0.379 |
|
| 2020 |
Bortolasci CC, Voigt C, Turner A, Mohebbi M, Gray L, Dodd S, Walder K, Berk M, Cotton SM, Malhi GS, Ng CH, Dowling N, Sarris J, Dean OM. Interleukin-6 and total antioxidant capacity levels following N-acetylcysteine and a combination nutraceutical intervention in a randomised controlled trial for bipolar disorder. Acta Neuropsychiatrica. 1-29. PMID 32600481 DOI: 10.1017/Neu.2020.25 |
0.408 |
|
| 2020 |
Hoare E, Callaly E, Berk M. Can Depression Be Prevented? If So, How? Jama Psychiatry. PMID 32579156 DOI: 10.1001/Jamapsychiatry.2020.1273 |
0.362 |
|
| 2020 |
Morris G, Walder KR, Berk M, Marx W, Walker AJ, Maes M, Puri BK. The interplay between oxidative stress and bioenergetic failure in neuropsychiatric illnesses: can we explain it and can we treat it? Molecular Biology Reports. PMID 32564227 DOI: 10.1007/S11033-020-05590-5 |
0.31 |
|
| 2020 |
Quidé Y, Bortolasci CC, Spolding B, Kidnapillai S, Watkeys OJ, Cohen-Woods S, Carr VJ, Berk M, Walder K, Green MJ. Systemic inflammation and grey matter volume in schizophrenia and bipolar disorder: Moderation by childhood trauma severity. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 110013. PMID 32540496 DOI: 10.1016/J.Pnpbp.2020.110013 |
0.331 |
|
| 2020 |
Lin CJ, Huang YH, Huang KY, Wu SI, Chang YH, Yeh HM, Chang CH, Lin IC, Huang HC, Sun FJ, Berk M, Liu SI. A Randomized Controlled Trial of Transcultural Validation of Group-Based Psychosocial Intervention for Patients with Bipolar Disorder. Psychiatry Research. 290: 113139. PMID 32512353 DOI: 10.1016/J.Psychres.2020.113139 |
0.407 |
|
| 2020 |
Berk M, Woods RL, Nelson MR, Shah RC, Reid CM, Storey E, Fitzgerald S, Lockery JE, Wolfe R, Mohebbi M, Dodd S, Murray AM, Stocks N, Fitzgerald PB, Mazza C, et al. Effect of Aspirin vs Placebo on the Prevention of Depression in Older People: A Randomized Clinical Trial. Jama Psychiatry. PMID 32492080 DOI: 10.1001/Jamapsychiatry.2020.1214 |
0.396 |
|
| 2020 |
Solmi M, Miola A, Croatto G, Pigato G, Favaro A, Fornaro M, Berk M, Smith L, Quevedo J, Maes M, Correll CU, Carvalho AF. How can we improve antidepressant adherence in the management of depression? A targeted review and 10 clinical recommendations. Revista Brasileira De Psiquiatria (Sao Paulo, Brazil : 1999). PMID 32491040 DOI: 10.1590/1516-4446-2020-0935 |
0.415 |
|
| 2020 |
Berk M, Vieta E, Dean OM. Anti-inflammatory treatment of bipolar depression: promise and disappointment. The Lancet. Psychiatry. 7: 467-468. PMID 32445674 DOI: 10.1016/S2215-0366(20)30155-3 |
0.379 |
|
| 2020 |
Carvalho AF, Solmi M, Sanches M, Machado MO, Stubbs B, Ajnakina O, Sherman C, Sun YR, Liu CS, Brunoni AR, Pigato G, Fernandes BS, Bortolato B, Husain MI, Dragioti E, ... ... Berk M, et al. Evidence-based umbrella review of 162 peripheral biomarkers for major mental disorders. Translational Psychiatry. 10: 152. PMID 32424116 DOI: 10.1038/S41398-020-0835-5 |
0.41 |
|
| 2020 |
Agustini B, Lotfaliany M, Woods RL, McNeil JJ, Nelson MR, Shah RC, Murray AM, Ernst ME, Reid CM, Tonkin A, Lockery JE, Williams LJ, Berk M, Mohebbi M. Patterns of Association between Depressive Symptoms and Chronic Medical Morbidities in Older Adults. Journal of the American Geriatrics Society. PMID 32402115 DOI: 10.1111/Jgs.16468 |
0.325 |
|
| 2020 |
Toenders YJ, Schmaal L, Harrison BJ, Dinga R, Berk M, Davey CG. Neurovegetative symptom subtypes in young people with major depressive disorder and their structural brain correlates. Translational Psychiatry. 10: 108. PMID 32312958 DOI: 10.1038/S41398-020-0787-9 |
0.395 |
|
| 2020 |
Lotter J, Möller M, Dean O, Berk M, Harvey BH. Studies on Haloperidol and Adjunctive α-Mangostin or Raw Linn Pericarp on Bio-Behavioral Markers in an Immune-Inflammatory Model of Schizophrenia in Male Rats. Frontiers in Psychiatry. 11: 121. PMID 32296347 DOI: 10.3389/Fpsyt.2020.00121 |
0.344 |
|
| 2020 |
Milaneschi Y, Lamers F, Berk M, Penninx BWJH. Depression Heterogeneity and Its Biological Underpinnings: Toward Immunometabolic Depression. Biological Psychiatry. PMID 32247527 DOI: 10.1016/J.Biopsych.2020.01.014 |
0.385 |
|
| 2020 |
Bortolasci CC, Marx W, Walker AJ, Hasebe K, Kavanagh BE, Morris MJ, Mohebbi M, Turner A, Gray L, Berk L, Walder K, Berk M, Dean OM. Minocycline for the treatment of mental health and neurological conditions: study protocol of a systematic review and meta-analysis. Bmj Open. 10: e035080. PMID 32198305 DOI: 10.1136/Bmjopen-2019-035080 |
0.436 |
|
| 2020 |
De Uribe Viloria N, Berk M. What is the potential of statins in the treatment of depression? Expert Review of Neurotherapeutics. 1-3. PMID 32191534 DOI: 10.1080/14737175.2020.1743685 |
0.371 |
|
| 2020 |
Morris G, Maes M, Berk M, Carvalho AF, Puri BK. Nutritional ketosis as an intervention to relieve astrogliosis: Possible therapeutic applications in the treatment of neurodegenerative and neuroprogressive disorders. European Psychiatry : the Journal of the Association of European Psychiatrists. 63: e8. PMID 32093791 DOI: 10.1192/J.Eurpsy.2019.13 |
0.334 |
|
| 2020 |
Guu TW, Mischoulon D, Sarris J, Hibbeln J, McNamara RK, Hamazaki K, Freeman MP, Maes M, Matsuoka YJ, Belmaker RH, Marx W, Pariante C, Berk M, Jacka F, Su KP. A multi-national, multi-disciplinary Delphi consensus study on using omega-3 polyunsaturated fatty acids (n-3 PUFAs) for the treatment of major depressive disorder. Journal of Affective Disorders. 265: 233-238. PMID 32090746 DOI: 10.1016/J.Jad.2020.01.050 |
0.399 |
|
| 2020 |
Williams LJ, Stuart AL, Berk M, Brennan-Olsen SL, Hodge JM, Cowdery S, Chandrasekaran V, Pasco JA. Bone health in bipolar disorder: a study protocol for a case-control study in Australia. Bmj Open. 10: e032821. PMID 32051309 DOI: 10.1136/Bmjopen-2019-032821 |
0.354 |
|
| 2020 |
Kloiber S, Rosenblat JD, Husain MI, Ortiz A, Berk M, Quevedo J, Vieta E, Maes M, Birmaher B, Soares JC, Carvalho AF. Neurodevelopmental pathways in bipolar disorder. Neuroscience and Biobehavioral Reviews. PMID 32035092 DOI: 10.1016/J.Neubiorev.2020.02.005 |
0.392 |
|
| 2020 |
Morris G, Puri BK, Carvalho A, Maes M, Berk M, Ruusunen A, Olive L. Induced ketosis as a treatment for neuroprogressive disorders: Food for thought? The International Journal of Neuropsychopharmacology. PMID 32034911 DOI: 10.1093/Ijnp/Pyaa008 |
0.39 |
|
| 2020 |
Agustini B, Mohebbi M, Woods RL, McNeil JJ, Nelson MR, Shah RC, Murray AM, Ernst ME, Reid CM, Tonkin A, Lockery JE, Berk M. The association of antihypertensive use and depressive symptoms in a large older population with hypertension living in Australia and the United States: a cross-sectional study. Journal of Human Hypertension. PMID 32001828 DOI: 10.1038/S41371-020-0303-Y |
0.376 |
|
| 2020 |
Stein DJ, Szatmari P, Gaebel W, Berk M, Vieta E, Maj M, de Vries YA, Roest AM, de Jonge P, Maercker A, Brewin CR, Pike KM, Grilo CM, Fineberg NA, Briken P, et al. Mental, behavioral and neurodevelopmental disorders in the ICD-11: an international perspective on key changes and controversies. Bmc Medicine. 18: 21. PMID 31983345 DOI: 10.1186/S12916-020-1495-2 |
0.351 |
|
| 2020 |
Costa MH, Kunz M, Nierenberg AA, Deckersbach T, Berk M, Magalhaes PVS. Clozapine and the Course of Bipolar Disorder in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 706743719900460. PMID 31958979 DOI: 10.1177/0706743719900460 |
0.407 |
|
| 2020 |
Velosa J, Delgado A, Finger E, Berk M, Kapczinski F, de Azevedo Cardoso T. Risk of dementia in bipolar disorder and the interplay of lithium: a systematic review and meta-analyses. Acta Psychiatrica Scandinavica. PMID 31954065 DOI: 10.1111/Acps.13153 |
0.354 |
|
| 2020 |
Berk M, Mohebbi M, Dean OM, Cotton SM, Chanen AM, Dodd S, Ratheesh A, Amminger GP, Phelan M, Weller A, Mackinnon A, Giorlando F, Baird S, Incerti L, Brodie RE, et al. Youth Depression Alleviation with Anti-inflammatory Agents (YoDA-A): a randomised clinical trial of rosuvastatin and aspirin. Bmc Medicine. 18: 16. PMID 31948461 DOI: 10.1186/S12916-019-1475-6 |
0.777 |
|
| 2020 |
Kidnapillai S, Wade B, Bortolasci CC, Panizzutti B, Spolding B, Connor T, Crowley T, Jamain S, Gray L, Leboyer M, Berk M, Walder K. Drugs used to treat bipolar disorder act via microRNAs to regulate expression of genes involved in neurite outgrowth. Journal of Psychopharmacology (Oxford, England). 269881119895534. PMID 31913086 DOI: 10.1177/0269881119895534 |
0.356 |
|
| 2019 |
Cotton SM, Berk M, Watson A, Wood S, Allott K, Bartholomeusz CF, Bortolasci CC, Walder K, O'Donoghue B, Dean OM, Chanen A, Amminger GP, McGorry PD, Burnside A, Uren J, et al. ENACT: a protocol for a randomised placebo-controlled trial investigating the efficacy and mechanisms of action of adjunctive N-acetylcysteine for first-episode psychosis. Trials. 20: 658. PMID 31779696 DOI: 10.1186/S13063-019-3786-5 |
0.409 |
|
| 2019 |
Ashton MM, Mohebbi M, Turner A, Marx W, Berk M, Malhi GS, Ng CH, Cotton SM, Dodd S, Sarris J, Hopwood M, Stubbs B, Dean OM. Physical Activity as a Predictor of Clinical Trial Outcomes in Bipolar Depression: A Subanalysis of a Mitochondrial-Enhancing Nutraceutical Randomized Controlled Trial. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 706743719889547. PMID 31775518 DOI: 10.1177/0706743719889547 |
0.386 |
|
| 2019 |
Rosenblat JD, Kurdyak P, Cosci F, Berk M, Maes M, Brunoni AR, Li M, Rodin G, McIntyre RS, Carvalho AF. Depression in the medically ill. The Australian and New Zealand Journal of Psychiatry. 4867419888576. PMID 31749372 DOI: 10.1177/0004867419888576 |
0.399 |
|
| 2019 |
Sarris J, Murphy J, Stough C, Mischoulon D, Bousman C, MacDonald P, Adams L, Nazareth S, Oliver G, Cribb L, Savage K, Menon R, Chamoli S, Berk M, Ng CH, et al. S-Adenosylmethionine (SAMe) monotherapy for depression: an 8-week double-blind, randomised, controlled trial. Psychopharmacology. PMID 31712971 DOI: 10.1007/S00213-019-05358-1 |
0.328 |
|
| 2019 |
Kowalczyk M, Szemraj J, Bliźniewska K, Maes M, Berk M, Su KP, Gałecki P. An immune gate of depression - Early neuroimmune development in the formation of the underlying depressive disorder. Pharmacological Reports : Pr. 71: 1299-1307. PMID 31706254 DOI: 10.1016/J.Pharep.2019.05.022 |
0.395 |
|
| 2019 |
Brunoni AR, Supasitthumrong T, Teixeira AL, Vieira EL, Gattaz WF, Benseñor IM, Lotufo PA, Lafer B, Berk M, Carvalho AF, Maes M. Differences in the immune-inflammatory profiles of unipolar and bipolar depression. Journal of Affective Disorders. 262: 8-15. PMID 31693974 DOI: 10.1016/J.Jad.2019.10.037 |
0.394 |
|
| 2019 |
Ashton MM, Dean OM, Marx W, Mohebbi M, Berk M, Malhi GS, Ng CH, Cotton SM, Dodd S, Sarris J, Hopwood M, Faye-Chauhan K, Kim Y, Dash SR, Jacka FN, et al. Diet quality, dietary inflammatory index and body mass index as predictors of response to adjunctive -acetylcysteine and mitochondrial agents in adults with bipolar disorder: A sub-study of a randomised placebo-controlled trial. The Australian and New Zealand Journal of Psychiatry. 4867419882497. PMID 31661974 DOI: 10.1177/0004867419882497 |
0.355 |
|
| 2019 |
van der Burg KP, Cribb L, Firth J, Karmacoska D, Mischoulon D, Byrne GJ, Bousman C, Stough C, Murphy J, Oliver G, Berk M, Ng CH, Sarris J. EPA and DHA as markers of nutraceutical treatment response in major depressive disorder. European Journal of Nutrition. PMID 31555976 DOI: 10.1007/S00394-019-02090-6 |
0.418 |
|
| 2019 |
Sethi R, Gómez-Coronado N, Walker AJ, Robertson OD, Agustini B, Berk M, Dodd S. Neurobiology and Therapeutic Potential of Cyclooxygenase-2 (COX-2) Inhibitors for Inflammation in Neuropsychiatric Disorders. Frontiers in Psychiatry. 10: 605. PMID 31551825 DOI: 10.3389/Fpsyt.2019.00605 |
0.439 |
|
| 2019 |
Morris G, Puri BK, Walker AJ, Maes M, Carvalho AF, Walder K, Berk M. Shared pathways for neuroprogression and somatoprogression in neuropsychiatric disorders. Neuroscience and Biobehavioral Reviews. PMID 31545987 DOI: 10.1016/J.Neubiorev.2019.09.025 |
0.369 |
|
| 2019 |
Firth J, Teasdale SB, Allott K, Siskind D, Marx W, Cotter J, Veronese N, Schuch F, Smith L, Solmi M, Carvalho AF, Vancampfort D, Berk M, Stubbs B, Sarris J. The efficacy and safety of nutrient supplements in the treatment of mental disorders: a meta-review of meta-analyses of randomized controlled trials. World Psychiatry : Official Journal of the World Psychiatric Association (Wpa). 18: 308-324. PMID 31496103 DOI: 10.1002/Wps.20672 |
0.447 |
|
| 2019 |
Ottesen NM, Meluken I, Frikke-Schmidt R, Plomgaard P, Scheike T, Fernandes BS, Berk M, Poulsen HE, Kessing LV, Miskowiak K, Vinberg M. Are remitted affective disorders and familial risk of affective disorders associated with metabolic syndrome, inflammation and oxidative stress? - a monozygotic twin study. Psychological Medicine. 1-10. PMID 31482770 DOI: 10.1017/S003329171900182X |
0.356 |
|
| 2019 |
Guu TW, Mischoulon D, Sarris J, Hibbeln J, McNamara RK, Hamazaki K, Freeman MP, Maes M, Matsuoka YJ, Belmaker RH, Jacka F, Pariante C, Berk M, Marx W, Su KP. International Society for Nutritional Psychiatry Research Practice Guidelines for Omega-3 Fatty Acids in the Treatment of Major Depressive Disorder. Psychotherapy and Psychosomatics. 1-11. PMID 31480057 DOI: 10.1159/000502652 |
0.403 |
|
| 2019 |
Faedda GL, Baldessarini RJ, Marangoni C, Bechdolf A, Berk M, Birmaher B, Conus P, DelBello MP, Duffy AC, Hillegers MHJ, Pfennig A, Post RM, Preisig M, Ratheesh A, Salvatore P, et al. An International Society of Bipolar Disorders task force report: Precursors and prodromes of bipolar disorder. Bipolar Disorders. PMID 31479581 DOI: 10.1111/Bdi.12831 |
0.379 |
|
| 2019 |
Chia MF, Cotton S, Filia K, Phelan M, Conus P, Jauhar S, Marwaha S, McGorry PD, Davey C, Berk M, Ratheesh A. Early intervention for bipolar disorder - Do current treatment guidelines provide recommendations for the early stages of the disorder? Journal of Affective Disorders. 257: 669-677. PMID 31377603 DOI: 10.1016/J.Jad.2019.07.062 |
0.352 |
|
| 2019 |
Davey CG, Chanen AM, Hetrick SE, Cotton SM, Ratheesh A, Amminger GP, Koutsogiannis J, Phelan M, Mullen E, Harrison BJ, Rice S, Parker AG, Dean OM, Weller A, Kerr M, ... ... Berk M, et al. The addition of fluoxetine to cognitive behavioural therapy for youth depression (YoDA-C): a randomised, double-blind, placebo-controlled, multicentre clinical trial. The Lancet. Psychiatry. PMID 31371212 DOI: 10.1016/S2215-0366(19)30215-9 |
0.398 |
|
| 2019 |
Post RM, Yatham LN, Vieta E, Berk M, Nierenberg AA. Beyond Evidence-based Treatment of Bipolar Disorder: Rational Pragmatic Approaches to Management. Bipolar Disorders. PMID 31343802 DOI: 10.1111/Bdi.12813 |
0.404 |
|
| 2019 |
Agustini B, Bocharova M, Walker AJ, Berk M, Young AH, Juruena MF. Has the sun set for seasonal affective disorder and HPA axis studies? A systematic review and future prospects. Journal of Affective Disorders. 256: 584-593. PMID 31299439 DOI: 10.1016/J.Jad.2019.06.060 |
0.405 |
|
| 2019 |
Jauhar S, Ratheesh A, Davey C, Yatham LN, McGorry PD, McGuire P, Berk M, Young AH. The case for improved care and provision of treatment for people with first-episode mania. The Lancet. Psychiatry. PMID 31248840 DOI: 10.1016/S2215-0366(19)30082-3 |
0.34 |
|
| 2019 |
Schön M, Mousa A, Berk M, Chia WL, Ukropec J, Majid A, Ukropcová B, de Courten B. The Potential of Carnosine in Brain-Related Disorders: A Comprehensive Review of Current Evidence. Nutrients. 11. PMID 31141890 DOI: 10.3390/Nu11061196 |
0.366 |
|
| 2019 |
Marx W, Lane M, Rocks T, Ruusunen A, Loughman A, Lopresti A, Marshall S, Berk M, Jacka F, Dean OM. Effect of saffron supplementation on symptoms of depression and anxiety: a systematic review and meta-analysis. Nutrition Reviews. PMID 31135916 DOI: 10.1093/Nutrit/Nuz023 |
0.366 |
|
| 2019 |
Tremain H, Fletcher K, Scott J, McEnery C, Berk M, Murray G. Does stage of illness influence recovery-focused outcomes after psychological treatment in bipolar disorder? A systematic review protocol. Systematic Reviews. 8: 125. PMID 31128591 DOI: 10.1186/S13643-019-1042-4 |
0.358 |
|
| 2019 |
Kavanagh BE, Williams LJ, Berk M, Turner A, Jackson HJ, Mohebbi M, Kanchanatawan B, Ashton MM, Ng CH, Maes M, Berk L, Malhi GS, Dowling N, Singh AB, Dean OM. Personality disorder and functioning in major depressive disorder: a nested study within a randomized controlled trial. Revista Brasileira De Psiquiatria (Sao Paulo, Brazil : 1999). PMID 31116261 DOI: 10.1590/1516-4446-2018-0308 |
0.439 |
|
| 2019 |
Agustini B, Mohebbi M, Woods RL, McNeil JJ, Nelson MR, Shah RC, Murray AM, Ernst ME, Reid CM, Tonkin A, Lockery JE, Berk M. Association Between Statin Use and Depressive Symptoms in a Large Community-Dwelling Older Population Living in Australia and the USA: A Cross-Sectional Study. Cns Drugs. PMID 31062260 DOI: 10.1007/S40263-019-00633-3 |
0.329 |
|
| 2019 |
Kavanagh BE, Brennan-Olsen SL, Turner A, Dean OM, Berk M, Ashton MM, Koivumaa-Honkanen H, Williams LJ. Role of personality disorder in randomised controlled trials of pharmacological interventions for adults with mood disorders: a protocol for a systematic review and meta-analysis. Bmj Open. 9: e025145. PMID 31048431 DOI: 10.1136/Bmjopen-2018-025145 |
0.424 |
|
| 2019 |
Mohebbi M, Agustini B, Woods RL, McNeil JJ, Nelson MR, Shah RC, Nguyen V, Storey E, Murray AM, Reid CM, Kirpach B, Wolfe RS, Lockery JE, Berk M. Prevalence of depressive symptoms and its associated factors among healthy community-dwelling older adults living in Australia and the United States. International Journal of Geriatric Psychiatry. PMID 30989707 DOI: 10.1002/Gps.5119 |
0.326 |
|
| 2019 |
Sharma V, Bergink V, Berk M, Chandra PS, Munk-Olsen T, Viguera AC, Yatham LN. Childbirth and prevention of bipolar disorder: an opportunity for change. The Lancet. Psychiatry. PMID 30981755 DOI: 10.1016/S2215-0366(19)30092-6 |
0.384 |
|
| 2019 |
Green J, Castle D, Berk M, Hair C, Loughman A, Cryan J, Nierenberg A, Athan E, Jacka F. Faecal microbiota transplants for depression - Who gives a crapsule? The Australian and New Zealand Journal of Psychiatry. 4867419839776. PMID 30957511 DOI: 10.1177/0004867419839776 |
0.307 |
|
| 2019 |
Ashton MM, Berk M, Ng CH, Hopwood M, Kavanagh B, Williams LJ, Sarris J, Dean OM. Nutraceuticals and nutritional supplements for the treatment of bipolar disorder: protocol for a systematic review. Bmj Open. 9: e025640. PMID 30948585 DOI: 10.1136/Bmjopen-2018-025640 |
0.435 |
|
| 2019 |
Lotfaliany M, Hoare E, Jacka FN, Kowal P, Berk M, Mohebbi M. Variation in the prevalence of depression and patterns of association, sociodemographic and lifestyle factors in community-dwelling older adults in six low- and middle-income countries. Journal of Affective Disorders. 251: 218-226. PMID 30927583 DOI: 10.1016/J.Jad.2019.01.054 |
0.309 |
|
| 2019 |
Ashton MM, Dean OM, Walker AJ, Bortolasci CC, Ng CH, Hopwood M, Harvey BH, Möller M, McGrath JJ, Marx W, Turner A, Dodd S, Scott JG, Khoo JP, Walder K, ... ... Berk M, et al. The Therapeutic Potential of Mangosteen Pericarp as an Adjunctive Therapy for Bipolar Disorder and Schizophrenia. Frontiers in Psychiatry. 10: 115. PMID 30918489 DOI: 10.3389/Fpsyt.2019.00115 |
0.406 |
|
| 2019 |
Turner A, McGrath JJ, Dean OM, Dodd S, Baker A, Cotton SM, Scott JG, Kavanagh BE, Ashton MM, Walker AJ, Brown E, Berk M. Protocol and Rationale: A 24-week Double-blind, Randomized, Placebo Controlled Trial of the Efficacy of Adjunctive Linn. (Mangosteen) Pericarp for Schizophrenia. Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology. 17: 297-307. PMID 30905130 DOI: 10.9758/Cpn.2019.17.2.297 |
0.3 |
|
| 2019 |
Kim SW, Kang HJ, Jhon M, Kim JW, Lee JY, Walker AJ, Agustini B, Kim JM, Berk M. Statins and Inflammation: New Therapeutic Opportunities in Psychiatry. Frontiers in Psychiatry. 10: 103. PMID 30890971 DOI: 10.3389/Fpsyt.2019.00103 |
0.452 |
|
| 2019 |
Bauer M, Glenn T, Alda M, Andreassen OA, Angelopoulos E, Ardau R, Ayhan Y, Baethge C, Bauer R, Baune BT, Becerra-Palars C, Bellivier F, Belmaker RH, Berk M, Bersudsky Y, et al. Association between solar insolation and a history of suicide attempts in bipolar I disorder. Journal of Psychiatric Research. 113: 1-9. PMID 30878786 DOI: 10.1016/J.Jpsychires.2019.03.001 |
0.334 |
|
| 2019 |
Kessing LV, Rytgaard HC, Gerds TA, Berk M, Ekstrøm CT, Andersen PK. New drug candidates for bipolar disorder - A nation-wide population-based study. Bipolar Disorders. PMID 30873730 DOI: 10.1111/Bdi.12772 |
0.331 |
|
| 2019 |
Fletcher K, Yang Y, Johnson SL, Berk M, Perich T, Cotton S, Jones S, Lapsley S, Michalak E, Murray G. Buffering against maladaptive perfectionism in bipolar disorder: The role of self-compassion. Journal of Affective Disorders. 250: 132-139. PMID 30852365 DOI: 10.1016/J.Jad.2019.03.003 |
0.36 |
|
| 2019 |
Berk M, Jacka FN. Diet and Depression-From Confirmation to Implementation. Jama. 321: 842-843. PMID 30835294 DOI: 10.1001/Jama.2019.0273 |
0.33 |
|
| 2019 |
Hidalgo-Mazzei D, Berk M, Cipriani A, Cleare AJ, Di Florio A, Dietch D, Geddes JR, Goodwin GM, Grunze H, Hayes JF, Jones I, Kasper S, Macritchie K, Hamish McAllister-Williams R, Morriss R, et al. Treatment-resistant and Multi-therapy resistant criteria for bipolar depression: A consensus definition - CORRIGENDUM. The British Journal of Psychiatry : the Journal of Mental Science. 1. PMID 30816078 DOI: 10.1192/Bjp.2019.36 |
0.33 |
|
| 2019 |
Chandrasekaran V, Brennan-Olsen SL, Stuart AL, Pasco JA, Berk M, Hodge JM, Williams LJ. Bipolar disorder and bone health: A systematic review. Journal of Affective Disorders. 249: 262-269. PMID 30784723 DOI: 10.1016/J.Jad.2019.02.013 |
0.374 |
|
| 2019 |
Cotton SM, Berk M, Jackson H, Murray G, Filia K, Hasty M, Chanen A, Davey C, Nelson B, Ratheesh A, MacNeil C. Improving functional outcomes in early-stage bipolar disorder: The protocol for the REsearch into COgnitive and behavioural VERsatility trial. Early Intervention in Psychiatry. PMID 30740882 DOI: 10.1111/Eip.12797 |
0.392 |
|
| 2019 |
Ellegaard PK, Licht RW, Nielsen RE, Dean OM, Berk M, Poulsen HE, Mohebbi M, Nielsen CT. The efficacy of adjunctive N-acetylcysteine in acute bipolar depression: A randomized placebo-controlled study. Journal of Affective Disorders. 245: 1043-1051. PMID 30699846 DOI: 10.1016/J.Jad.2018.10.083 |
0.392 |
|
| 2019 |
Sarris J, Byrne GJ, Stough C, Bousman C, Mischoulon D, Murphy J, Macdonald P, Adams L, Nazareth S, Oliver G, Cribb L, Savage K, Menon R, Chamoli S, Berk M, et al. Nutraceuticals for major depressive disorder- more is not merrier: An 8-week double-blind, randomised, controlled trial. Journal of Affective Disorders. 245: 1007-1015. PMID 30699842 DOI: 10.1016/J.Jad.2018.11.092 |
0.372 |
|
| 2019 |
Robertson OD, Coronado NG, Sethi R, Berk M, Dodd S. Putative neuroprotective pharmacotherapies to target the staged progression of mental illness. Early Intervention in Psychiatry. PMID 30690898 DOI: 10.1111/Eip.12775 |
0.401 |
|
| 2019 |
Berk M, Turner A, Malhi GS, Ng C, Cotton SM, Dodd S, Samuni Y, Tanious M, McAulay C, Dowling N, Sarris J, Owen L, Waterdrinker A, Smith D, Dean OM. A randomised controlled trial of a mitochondrial therapeutic target for bipolar depression: mitochondrial agents, N-acetylcysteine, and placebo. Bmc Medicine. 17: 18. PMID 30678686 DOI: 10.1186/S12916-019-1257-1 |
0.378 |
|
| 2019 |
Hoare E, Jacka F, Berk M. The impact of urbanization on mood disorders: an update of recent evidence. Current Opinion in Psychiatry. PMID 30676331 DOI: 10.1097/Yco.0000000000000487 |
0.39 |
|
| 2019 |
Dean OM, Gray K, Dodd S, Villagonzalo KA, Brown E, Tonge B, Berk M, Byrne LK. Does N-acetylcysteine improve behaviour in children with autism?: A mixed-methods analysis of the effects of N-acetylcysteine Journal of Intellectual & Developmental Disability. 44: 474-480. DOI: 10.3109/13668250.2017.1413079 |
0.338 |
|
| 2019 |
Hoare E, Thorisdóttir IE, Kristjansson AL, Sigfusdóttir ID, Hayward J, Allender S, Strugnell C, Reavley N, Patton G, Berk M, Jacka F. Lessons from Iceland: Developing scalable and sustainable community approaches for the prevention of mental disorders in young Australians Mental Health & Prevention. 15: 200166. DOI: 10.1016/J.Mhp.2019.200166 |
0.387 |
|
| 2019 |
Ottesen NM, Meluken I, Frikke-Schmidt R, Plomgaard P, Henrik EP, Scheike T, Fernandes B, Dodd S, Berk M, Kessing LV, Miskowiak K, Vinberg M. P.4.08 Metabolic syndrome, inflammation and oxidative stress as potential risk factors for affective disorders – a twin study European Neuropsychopharmacology. 29. DOI: 10.1016/J.Euroneuro.2019.01.098 |
0.314 |
|
| 2019 |
Ashton M, Dean OM, Marx W, Mohebi M, Berk M, Malhi GS, Ng C, Cotton SM, Dodd S, Sarris J, Hopwood M, Voigt C, Faye-Chauhan K, Kim Y, Dash SR, et al. Diet quality, dietary inflammatory index and body composition as predictors of N-acetylcysteine and mitochondrial agents efficacy in bipolar disorder European Neuropsychopharmacology. 29. DOI: 10.1016/J.Euroneuro.2018.11.1042 |
0.327 |
|
| 2018 |
Jacka FN, O'Neil A, Itsiopoulos C, Opie R, Cotton S, Mohebbi M, Castle D, Dash S, Mihalopoulos C, Chatterton ML, Brazionis L, Dean OM, Hodge A, Berk M. The SMILES trial: an important first step. Bmc Medicine. 16: 237. PMID 30591059 DOI: 10.1186/S12916-018-1228-Y |
0.358 |
|
| 2018 |
Jacka FN, O'Neil A, Opie R, Itsiopoulos C, Cotton S, Mohebbi M, Castle D, Dash S, Mihalopoulos C, Chatterton ML, Brazionis L, Dean OM, Hodge AM, Berk M. Correction to: A randomised controlled trial of dietary improvement for adults with major depression (the 'SMILES' trial). Bmc Medicine. 16: 236. PMID 30591046 DOI: 10.1186/S12916-018-1220-6 |
0.328 |
|
| 2018 |
Quidé Y, Bortolasci CC, Spolding B, Kidnapillai S, Watkeys OJ, Cohen-Woods S, Berk M, Carr VJ, Walder K, Green MJ. Association between childhood trauma exposure and pro-inflammatory cytokines in schizophrenia and bipolar-I disorder. Psychological Medicine. 1-9. PMID 30560764 DOI: 10.1017/S0033291718003690 |
0.344 |
|
| 2018 |
Salagre E, Dodd S, Aedo A, Rosa A, Amoretti S, Pinzon J, Reinares M, Berk M, Kapczinski FP, Vieta E, Grande I. Toward Precision Psychiatry in Bipolar Disorder: Staging 2.0. Frontiers in Psychiatry. 9: 641. PMID 30555363 DOI: 10.3389/Fpsyt.2018.00641 |
0.324 |
|
| 2018 |
Hidalgo-Mazzei D, Berk M, Cipriani A, Cleare AJ, Florio AD, Dietch D, Geddes JR, Goodwin GM, Grunze H, Hayes JF, Jones I, Kasper S, Macritchie K, McAllister-Williams RH, Morriss R, et al. Treatment-resistant and multi-therapy-resistant criteria for bipolar depression: consensus definition. The British Journal of Psychiatry : the Journal of Mental Science. 1-9. PMID 30520709 DOI: 10.1192/Bjp.2018.257 |
0.432 |
|
| 2018 |
Aslam H, Green J, Jacka FN, Collier F, Berk M, Pasco J, Dawson SL. Fermented foods, the gut and mental health: a mechanistic overview with implications for depression and anxiety. Nutritional Neuroscience. 1-13. PMID 30415609 DOI: 10.1080/1028415X.2018.1544332 |
0.344 |
|
| 2018 |
Agustini B, Berk M. Medications With Depression as an Adverse Effect. Jama. 320: 1815. PMID 30398595 DOI: 10.1001/Jama.2018.12390 |
0.339 |
|
| 2018 |
Davis J, Desmond M, Berk M. Lithium and nephrotoxicity: a literature review of approaches to clinical management and risk stratification. Bmc Nephrology. 19: 305. PMID 30390660 DOI: 10.1186/S12882-018-1101-4 |
0.343 |
|
| 2018 |
Fornaro M, Anastasia A, Novello S, Fusco A, Pariano R, De Berardis D, Solmi M, Veronese N, Stubbs B, Vieta E, Berk M, de Bartolomeis A, Carvalho AF. The Emergence of loss of efficacy during Antidepressant Drug Treatment for Major Depressive Disorder: An Integrative Review of Evidence, Mechanisms, and Clinical Implications. Pharmacological Research. PMID 30385364 DOI: 10.1016/J.Phrs.2018.10.025 |
0.445 |
|
| 2018 |
Parker G, Tavella G, Macqueen G, Berk M, Grunze H, Deckersbach T, Dunner DL, Sajatovic M, Amsterdam JD, Ketter TA, Yatham LN, Kessing LV, Bassett D, Zimmerman M, Fountoulakis KN, et al. Revising Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, criteria for the bipolar disorders: Phase I of the AREDOC project. The Australian and New Zealand Journal of Psychiatry. 4867418808382. PMID 30378461 DOI: 10.1177/0004867418808382 |
0.359 |
|
| 2018 |
Ashton MM, Berk M, Ng CH, Hopwood M, Dodd S, Turner A, Brown E, Jacka FN, Cotton SM, Khoo JP, Chatterton ML, Kavanagh BE, Nadjidai SE, Lo Monaco SL, Harvey BH, et al. Efficacy of adjunctive Garcinia mangostana Linn (mangosteen) pericarp for bipolar depression: study protocol for a proof-of-concept trial. Revista Brasileira De Psiquiatria (Sao Paulo, Brazil : 1999). PMID 30328970 DOI: 10.1590/1516-4446-2018-0114 |
0.423 |
|
| 2018 |
Morris G, Fernandes BS, Puri BK, Walker AJ, Carvalho AF, Berk M. Leaky brain in neurological and psychiatric disorders: Drivers and consequences. The Australian and New Zealand Journal of Psychiatry. 52: 924-948. PMID 30231628 DOI: 10.1177/0004867418796955 |
0.323 |
|
| 2018 |
V Kessing L, Rytgaard HC, Gerds TA, Berk M, Ekstrøm CT, Andersen PK. New drug candidates for depression - a nationwide population-based study. Acta Psychiatrica Scandinavica. PMID 30182363 DOI: 10.1111/Acps.12957 |
0.33 |
|
| 2018 |
Bauer R, Glenn T, Strejilevich S, Conell J, Alda M, Ardau R, Baune BT, Berk M, Bersudsky Y, Bilderbeck A, Bocchetta A, Castro AMP, Cheung EYW, Chillotti C, Choppin S, et al. Internet use by older adults with bipolar disorder: international survey results. International Journal of Bipolar Disorders. 6: 20. PMID 30178112 DOI: 10.1186/S40345-018-0127-7 |
0.321 |
|
| 2018 |
Gómez-Coronado N, Sethi R, Bortolasci CC, Arancini L, Berk M, Dodd S. A review of the neurobiological underpinning of comorbid substance use and mood disorders. Journal of Affective Disorders. 241: 388-401. PMID 30145509 DOI: 10.1016/J.Jad.2018.08.041 |
0.387 |
|
| 2018 |
Sarris J, Byrne GJ, Bousman C, Stough C, Murphy J, MacDonald P, Adams L, Nazareth S, Oliver G, Cribb L, Savage K, Menon R, Chamoli S, Berk M, Ng C, et al. Adjunctive S-adenosylmethionine (SAMe) in treating non-remittent major depressive disorder: An 8-week double-blind, randomized, controlled trial. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. PMID 30115553 DOI: 10.1016/J.Euroneuro.2018.07.098 |
0.404 |
|
| 2018 |
Chowdhury EK, Berk M, Nelson MR, Wing LMH, Reid CM. Association of depression with mortality in an elderly treated hypertensive population. International Psychogeriatrics. 1-11. PMID 30099979 DOI: 10.1017/S1041610218000856 |
0.334 |
|
| 2018 |
Young CL, Trapani K, Dawson S, O'Neil A, Kay-Lambkin F, Berk M, Jacka FN. Efficacy of online lifestyle interventions targeting lifestyle behaviour change in depressed populations: A systematic review. The Australian and New Zealand Journal of Psychiatry. 4867418788659. PMID 30052063 DOI: 10.1177/0004867418788659 |
0.359 |
|
| 2018 |
Gold AK, Peters AT, Otto MW, Sylvia LG, Magalhaes PVDS, Berk M, Dougherty DD, Miklowitz DJ, Frank E, Nierenberg AA, Deckersbach T. The impact of substance use disorders on recovery from bipolar depression: Results from the Systematic Treatment Enhancement Program for Bipolar Disorder psychosocial treatment trial. The Australian and New Zealand Journal of Psychiatry. 4867418788172. PMID 30047784 DOI: 10.1177/0004867418788172 |
0.444 |
|
| 2018 |
O'Donoghue B, Francey SM, Nelson B, Ratheesh A, Allott K, Graham J, Baldwin L, Alvarez-Jimenez M, Thompson A, Fornito A, Polari A, Berk M, Macneil C, Crisp K, Pantelis C, et al. Staged treatment and acceptability guidelines in early psychosis study (STAGES): A randomized placebo controlled trial of intensive psychosocial treatment plus or minus antipsychotic medication for first-episode psychosis with low-risk of self-harm or aggression. Study protocol and baseline characteristics of participants. Early Intervention in Psychiatry. PMID 30024100 DOI: 10.1111/Eip.12716 |
0.352 |
|
| 2018 |
Panizzutti B, Bortolasci C, Hasebe K, Kidnapillai S, Gray L, Walder K, Berk M, Mohebbi M, Dodd S, Gama C, Magalhães PV, Cotton SM, Kapczinski F, Bush AI, Malhi GS, et al. Mediator effects of parameters of inflammation and neurogenesis from a N-acetyl cysteine clinical-trial for bipolar depression. Acta Neuropsychiatrica. 1-8. PMID 30008280 DOI: 10.1017/Neu.2018.13 |
0.399 |
|
| 2018 |
Fletcher K, Foley F, Thomas N, Michalak E, Berk L, Berk M, Bowe S, Cotton S, Engel L, Johnson SL, Jones S, Kyrios M, Lapsley S, Mihalopoulos C, Perich T, et al. Web-based intervention to improve quality of life in late stage bipolar disorder (ORBIT): randomised controlled trial protocol. Bmc Psychiatry. 18: 221. PMID 30001704 DOI: 10.1186/S12888-018-1805-9 |
0.327 |
|
| 2018 |
Bruschi A, Mazza M, Camardese G, Calò S, Palumbo C, Mandelli L, Callea A, Gori A, Di Nicola M, Marano G, Berk M, di Sciascio G, Janiri L. Psychopathological Features of Bipolar Depression: Italian Validation of the Bipolar Depression Rating Scale (I-BDRS). Frontiers in Psychology. 9: 1047. PMID 29977223 DOI: 10.3389/Fpsyg.2018.01047 |
0.423 |
|
| 2018 |
Kidnapillai S, Bortolasci CC, Udawela M, Panizzutti B, Spolding B, Connor T, Sanigorski A, Dean OM, Crowley T, Jamain S, Gray L, Scarr E, Leboyer M, Dean B, Berk M, et al. The use of a Gene Expression Signature and Connectivity Map to repurpose drugs for Bipolar Disorder. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 1-28. PMID 29956574 DOI: 10.1080/15622975.2018.1492734 |
0.305 |
|
| 2018 |
Gliddon E, Cosgrove V, Berk L, Lauder S, Mohebbi M, Grimm D, Dodd S, Coulson C, Raju K, Suppes T, Berk M. A randomized controlled trial of MoodSwings 2.0: An internet-based self-management program for bipolar disorder. Bipolar Disorders. PMID 29931798 DOI: 10.1111/Bdi.12669 |
0.415 |
|
| 2018 |
Dodd S, Walker AJ, Brnabic AJM, Hong N, Burns A, Berk M. Incidence and characteristics of the nocebo response from meta-analyses of the placebo arms of clinical trials of olanzapine for bipolar disorder. Bipolar Disorders. PMID 29926533 DOI: 10.1111/Bdi.12662 |
0.339 |
|
| 2018 |
Mohebbi M, Dodd S, Dean OM, Berk M. Patient centric measures for a patient centric era: Agreement and convergent between ratings on The Patient Global Impression of Improvement (PGI-I) scale and the Clinical Global Impressions - Improvement (CGI-S) scale in bipolar and major depressive disorder. European Psychiatry : the Journal of the Association of European Psychiatrists. 53: 17-22. PMID 29859377 DOI: 10.1016/J.Eurpsy.2018.05.006 |
0.425 |
|
| 2018 |
Chatterton ML, Mihalopoulos C, O'Neil A, Itsiopoulos C, Opie R, Castle D, Dash S, Brazionis L, Berk M, Jacka F. Economic evaluation of a dietary intervention for adults with major depression (the "SMILES" trial). Bmc Public Health. 18: 599. PMID 29783983 DOI: 10.1186/S12889-018-5504-8 |
0.355 |
|
| 2018 |
Morris G, Stubbs B, Köhler CA, Walder K, Slyepchenko A, Berk M, Carvalho AF. The putative role of oxidative stress and inflammation in the pathophysiology of sleep dysfunction across neuropsychiatric disorders: Focus on chronic fatigue syndrome, bipolar disorder and multiple sclerosis. Sleep Medicine Reviews. PMID 29759891 DOI: 10.1016/J.Smrv.2018.03.007 |
0.322 |
|
| 2018 |
McGorry PD, Ratheesh A, Berk M, Conus P. 'Is "early intervention" in bipolar disorder what it claims to be?' Malhi et al. Bipolar Disorders. 20: 181-183. PMID 29737634 DOI: 10.1111/Bdi.12641 |
0.301 |
|
| 2018 |
Price JB, Bronars C, Erhardt S, Cullen KR, Schwieler L, Berk M, Walder K, McGee SL, Frye MA, Tye SJ. Bioenergetics and synaptic plasticity as potential targets for individualizing treatment for depression. Neuroscience and Biobehavioral Reviews. PMID 29656032 DOI: 10.1016/J.Neubiorev.2018.04.002 |
0.381 |
|
| 2018 |
Ellegaard PK, Licht RW, Poulsen HE, Nielsen RE, Berk M, Dean OM, Mohebbi M, Nielsen CT. Add-on treatment with N-acetylcysteine for bipolar depression: a 24-week randomized double-blind parallel group placebo-controlled multicentre trial (NACOS-study protocol). International Journal of Bipolar Disorders. 6: 11. PMID 29619634 DOI: 10.1186/S40345-018-0117-9 |
0.47 |
|
| 2018 |
Davis J, Desmond M, Berk M. Lithium and nephrotoxicity: Unravelling the complex pathophysiological threads of the lightest metal. Nephrology (Carlton, Vic.). PMID 29607573 DOI: 10.1111/Nep.13263 |
0.3 |
|
| 2018 |
Pereira C, Chavarria V, Vian J, Ashton MM, Berk M, Marx W, Dean OM. Mitochondrial Agents for Bipolar Disorder. The International Journal of Neuropsychopharmacology. PMID 29596661 DOI: 10.1093/Ijnp/Pyy018 |
0.388 |
|
| 2018 |
Yatham LN, Kennedy SH, Parikh SV, Schaffer A, Bond DJ, Frey BN, Sharma V, Goldstein BI, Rej S, Beaulieu S, Alda M, MacQueen G, Milev RV, Ravindran A, O'Donovan C, ... ... Berk M, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder. Bipolar Disorders. PMID 29536616 DOI: 10.1111/Bdi.12609 |
0.432 |
|
| 2018 |
Vieta E, Berk M, Schulze TG, Carvalho AF, Suppes T, Calabrese JR, Gao K, Miskowiak KW, Grande I. Bipolar disorders. Nature Reviews. Disease Primers. 4: 18008. PMID 29516993 DOI: 10.1038/nrdp.2018.8 |
0.348 |
|
| 2018 |
Dandash O, Yücel M, Daglas R, Pantelis C, McGorry P, Berk M, Fornito A. Differential effect of quetiapine and lithium on functional connectivity of the striatum in first episode mania. Translational Psychiatry. 8: 59. PMID 29507281 DOI: 10.1038/S41398-018-0108-8 |
0.311 |
|
| 2018 |
Bortolasci CC, Spolding B, Callaly E, Martin S, Panizzutti B, Kidnapillai S, Connor T, Hasebe K, Mohebbi M, Dean OM, McGee SL, Dodd S, Gray L, Berk M, Walder K. Mechanisms Underpinning the Polypharmacy Effects of Medications in Psychiatry. The International Journal of Neuropsychopharmacology. PMID 29471411 DOI: 10.1093/Ijnp/Pyy014 |
0.334 |
|
| 2018 |
Berk M, Boyce P, Hamilton A, Morris G, Outhred T, Das P, Bassett D, Baune BT, Lyndon B, Mulder R, Parker G, Singh AB, Malhi GS. Personality: Distraction or driver in the diagnosis of depression. Personality and Mental Health. PMID 29457699 DOI: 10.1002/Pmh.1411 |
0.346 |
|
| 2018 |
Zheng W, Zhang QE, Cai DB, Yang XH, Qiu Y, Ungvari GS, Ng CH, Berk M, Ning YP, Xiang YT. N-acetylcysteine for major mental disorders: a systematic review and meta-analysis of randomized controlled trials. Acta Psychiatrica Scandinavica. PMID 29457216 DOI: 10.1111/Acps.12862 |
0.438 |
|
| 2018 |
Adams SD, Kouzani AZ, Tye SJ, Bennet KE, Berk M. An investigation into closed-loop treatment of neurological disorders based on sensing mitochondrial dysfunction. Journal of Neuroengineering and Rehabilitation. 15: 8. PMID 29439744 DOI: 10.1186/S12984-018-0349-Z |
0.341 |
|
| 2018 |
Vieta E, Salagre E, Grande I, Carvalho AF, Fernandes BS, Berk M, Birmaher B, Tohen M, Suppes T. Early Intervention in Bipolar Disorder. The American Journal of Psychiatry. appiajp201717090972. PMID 29361850 DOI: 10.1176/Appi.Ajp.2017.17090972 |
0.417 |
|
| 2018 |
Morris G, Reiche EMV, Murru A, Carvalho AF, Maes M, Berk M, Puri BK. Multiple Immune-Inflammatory and Oxidative and Nitrosative Stress Pathways Explain the Frequent Presence of Depression in Multiple Sclerosis. Molecular Neurobiology. PMID 29294244 DOI: 10.1007/S12035-017-0843-5 |
0.353 |
|
| 2018 |
Stein DJ, Naudé PJ, Berk M. Stress, Depression, and Inflammation: Molecular and Microglial Mechanisms. Biological Psychiatry. 83: 5-6. PMID 29173706 DOI: 10.1016/J.Biopsych.2017.10.025 |
0.326 |
|
| 2018 |
Muñoz ES, McGuiness A, Jacka F, Vieta E, Grande I, Carvalho AF, Berk M, Fernandes BS. Depression is associated with increased insulin resistance: a meta-analysis European Neuropsychopharmacology. 28. DOI: 10.1016/J.Euroneuro.2017.12.091 |
0.402 |
|
| 2018 |
Debnath M, Berk M, Leboyer M, Tamouza R. The MHC/HLA Gene Complex in Major Psychiatric Disorders: Emerging Roles and Implications Current Behavioral Neuroscience Reports. 5: 179-188. DOI: 10.1007/S40473-018-0155-8 |
0.393 |
|
| 2017 |
Firth J, Carney R, Stubbs B, Teasdale SB, Vancampfort D, Ward PB, Berk M, Sarris J. Nutritional Deficiencies and Clinical Correlates in First-Episode Psychosis: A Systematic Review and Meta-analysis. Schizophrenia Bulletin. PMID 29206972 DOI: 10.1093/Schbul/Sbx162 |
0.35 |
|
| 2017 |
Paterson J, Medvedev ON, Sumich A, Tautolo ES, Krägeloh CU, Sisk R, McNamara RK, Berk M, Narayanan A, Siegert RJ. Distinguishing transient versus stable aspects of depression in New Zealand Pacific Island children using Generalizability Theory. Journal of Affective Disorders. 227: 698-704. PMID 29174744 DOI: 10.1016/J.Jad.2017.11.075 |
0.355 |
|
| 2017 |
Oberholzer I, Möller M, Holland B, Dean OM, Berk M, Harvey BH. Garcinia mangostana Linn displays antidepressant-like and pro-cognitive effects in a genetic animal model of depression: a bio-behavioral study in the Flinders Sensitive Line rat. Metabolic Brain Disease. PMID 29101602 DOI: 10.1007/S11011-017-0144-8 |
0.333 |
|
| 2017 |
Dodd S, Mitchell PB, Bauer M, Yatham L, Young AH, Kennedy SH, Williams L, Suppes T, Lopez Jaramillo C, Trivedi MH, Fava M, Rush AJ, McIntyre RS, Thase ME, Lam RW, ... ... Berk M, et al. Monitoring for antidepressant-associated adverse events in the treatment of patients with major depressive disorder: An international consensus statement. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 1-19. PMID 28984491 DOI: 10.1080/15622975.2017.1379609 |
0.427 |
|
| 2017 |
Marx W, Moseley G, Berk M, Jacka F. Nutritional psychiatry: the present state of the evidence. The Proceedings of the Nutrition Society. 1-10. PMID 28942748 DOI: 10.1017/S0029665117002026 |
0.326 |
|
| 2017 |
Roomruangwong C, Anderson G, Berk M, Stoyanov D, Carvalho AF, Maes M. A neuro-immune, neuro-oxidative and neuro-nitrosative model of prenatal and postpartum depression. Progress in Neuro-Psychopharmacology & Biological Psychiatry. PMID 28941769 DOI: 10.1016/J.Pnpbp.2017.09.015 |
0.432 |
|
| 2017 |
Berk M, Post R, Ratheesh A, Gliddon E, Singh A, Vieta E, Carvalho AF, Ashton MM, Berk L, Cotton SM, McGorry PD, Fernandes BS, Yatham LN, Dodd S. Staging in bipolar disorder: from theoretical framework to clinical utility. World Psychiatry : Official Journal of the World Psychiatric Association (Wpa). 16: 236-244. PMID 28941093 DOI: 10.1002/Wps.20441 |
0.382 |
|
| 2017 |
Duailibi MS, Cordeiro Q, Brietzke E, Ribeiro M, LaRowe S, Berk M, Trevizol AP. N-acetylcysteine in the treatment of craving in substance use disorders: Systematic review and meta-analysis. The American Journal On Addictions. PMID 28898494 DOI: 10.1111/Ajad.12620 |
0.369 |
|
| 2017 |
Mohebbi M, Nguyen V, McNeil JJ, Woods RL, Nelson MR, Shah RC, Storey E, Murray AM, Reid CM, Kirpach B, Wolfe R, Lockery JE, Berk M. Psychometric properties of a short form of the Center for Epidemiologic Studies Depression (CES-D-10) scale for screening depressive symptoms in healthy community dwelling older adults. General Hospital Psychiatry. PMID 28890280 DOI: 10.1016/J.Genhosppsych.2017.08.002 |
0.332 |
|
| 2017 |
Quirk SE, Stuart AL, Berk M, Pasco JA, Brennan Olsen SL, Koivumaa-Honkanen H, Honkanen R, Lukkala PS, Chanen AM, Kotowicz M, Williams LJ. Personality disorder is an excess risk factor for physical multimorbidity among women with mental state disorders. Psychiatry Research. 257: 546-549. PMID 28888138 DOI: 10.1016/J.Psychres.2017.08.010 |
0.375 |
|
| 2017 |
Baune BT, Malhi GS, Morris G, Outhred T, Hamilton A, Das P, Bassett D, Berk M, Boyce P, Lyndon B, Mulder R, Parker G, Singh AB. Cognition in depression: Can we THINC-it better? Journal of Affective Disorders. 225: 559-562. PMID 28869910 DOI: 10.1016/J.Jad.2017.08.080 |
0.374 |
|
| 2017 |
Dipnall JF, Pasco JA, Berk M, Williams LJ, Dodd S, Jacka FN, Meyer D. Getting RID of the blues: Formulating a Risk Index for Depression (RID) using structural equation modeling. The Australian and New Zealand Journal of Psychiatry. 4867417726860. PMID 28856902 DOI: 10.1177/0004867417726860 |
0.331 |
|
| 2017 |
Berger ME, Smesny S, Kim SW, Davey CG, Rice S, Sarnyai Z, Schlögelhofer M, Schäfer MR, Berk M, McGorry PD, Amminger GP. Omega-6 to omega-3 polyunsaturated fatty acid ratio and subsequent mood disorders in young people with at-risk mental states: a 7-year longitudinal study. Translational Psychiatry. 7: e1220. PMID 28850110 DOI: 10.1038/Tp.2017.190 |
0.43 |
|
| 2017 |
Boyce P, Lyndon B, Outhred T, Hamilton A, Morris G, Das P, Bassett D, Baune BT, Berk M, Mulder R, Parker G, Singh AB, Malhi GS. Priorities in the assessment and management of perinatal mood disorders. The Australian and New Zealand Journal of Psychiatry. 4867417727354. PMID 28835110 DOI: 10.1177/0004867417727354 |
0.343 |
|
| 2017 |
Bassett D, Mulder R, Outhred T, Hamilton A, Morris G, Das P, Berk M, Baune BT, Boyce P, Lyndon B, Parker G, Singh AB, Malhi GS. Defining disorders with permeable borders: you say bipolar, I say borderline! Bipolar Disorders. 19: 320-323. PMID 28833995 DOI: 10.1111/Bdi.12528 |
0.377 |
|
| 2017 |
Barbé-Tuana FM, Parisi MM, Panizzutti BS, Fries GR, Grun LK, Guma FT, Kapczinski F, Berk M, Gama CS, Rosa AR. Analyzing leukocyte telomere length in bipolar disorder: Authors' reply. Revista Brasileira De Psiquiatria (Sao Paulo, Brazil : 1999). 39: 275-276. PMID 28813116 DOI: 10.1590/1516-4446-2017-2350 |
0.365 |
|
| 2017 |
Barbosa IG, Vaz GN, Rocha NP, Machado-Vieira R, Ventura MRD, Huguet RB, Bauer ME, Berk M, Teixeira AL. Plasma Levels of Tumor Necrosis Factor Superfamily Molecules Are Increased in Bipolar Disorder. Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology. 15: 269-275. PMID 28783937 DOI: 10.9758/Cpn.2017.15.3.269 |
0.338 |
|
| 2017 |
Vian J, Pereira C, Chavarria V, Köhler C, Stubbs B, Quevedo J, Kim SW, Carvalho AF, Berk M, Fernandes BS. The renin-angiotensin system: a possible new target for depression. Bmc Medicine. 15: 144. PMID 28760142 DOI: 10.1186/S12916-017-0916-3 |
0.383 |
|
| 2017 |
Lyndon B, Parker G, Morris G, Das P, Outhred T, Hamilton A, Bassett D, Baune BT, Berk M, Boyce P, Mulder R, Singh AB, Malhi GS. Is atypical depression simply a typical depression with unusual symptoms? The Australian and New Zealand Journal of Psychiatry. 4867417721020. PMID 28754056 DOI: 10.1177/0004867417721020 |
0.358 |
|
| 2017 |
Bauer M, Glenn T, Alda M, Aleksandrovich MA, Andreassen OA, Angelopoulos E, Ardau R, Ayhan Y, Baethge C, Bharathram SR, Bauer R, Baune BT, Becerra-Palars C, Bellivier F, Belmaker RH, ... Berk M, et al. Solar insolation in springtime influences age of onset of bipolar I disorder. Acta Psychiatrica Scandinavica. PMID 28722128 DOI: 10.1111/Acps.12772 |
0.363 |
|
| 2017 |
Landucci Bonifácio K, Sabbatini Barbosa D, Gastaldello Moreira E, de Farias CC, Higachi L, Camargo AEI, Favaro Soares J, Odebrecht Vargas H, Nunes SOV, Berk M, Dodd S, Maes M. Indices of insulin resistance and glucotoxicity are not associated with bipolar disorder or major depressive disorder, but are differently associated with inflammatory, oxidative and nitrosative biomarkers. Journal of Affective Disorders. 222: 185-194. PMID 28710952 DOI: 10.1016/J.Jad.2017.07.010 |
0.373 |
|
| 2017 |
Bauer R, Conell J, Glenn T, Alda M, Ardau R, Baune BT, Berk M, Bersudsky Y, Bilderbeck A, Bocchetta A, Bossini L, Castro AMP, Cheung EYW, Chillotti C, Choppin S, et al. International multi-site survey on the use of online support groups in bipolar disorder. Nordic Journal of Psychiatry. 1-4. PMID 28696841 DOI: 10.1080/08039488.2017.1334819 |
0.359 |
|
| 2017 |
Kim SW, Kang HJ, Bae KY, Il-SeonShin, JoonHong Y, YoungkeunAhn, Jeong MH, Berk M, Yoon JS, Kim JM. Interactions between pro-inflammatory cytokines and statins on depression in patients with acute coronary syndrome. Progress in Neuro-Psychopharmacology & Biological Psychiatry. PMID 28689006 DOI: 10.1016/J.Pnpbp.2017.07.003 |
0.328 |
|
| 2017 |
Parker G, Bassett D, Outhred T, Morris G, Hamilton A, Das P, Baune BT, Berk M, Boyce P, Lyndon B, Mulder R, Singh AB, Malhi GS. Defining melancholia: A core mood disorder. Bipolar Disorders. 19: 235-237. PMID 28599349 DOI: 10.1111/Bdi.12501 |
0.303 |
|
| 2017 |
Fernandes BS, Berk M. Staging in bipolar disorder: one step closer to precision psychiatry. Revista Brasileira De Psiquiatria (Sao Paulo, Brazil : 1999). 39: 88-89. PMID 28591270 DOI: 10.1590/1516-4446-2017-3902 |
0.355 |
|
| 2017 |
Dean OM, Kanchanatawan B, Ashton M, Mohebbi M, Ng CH, Maes M, Berk L, Sughondhabirom A, Tangwongchai S, Singh AB, McKenzie H, Smith DJ, Malhi GS, Dowling N, Berk M. Adjunctive minocycline treatment for major depressive disorder: A proof of concept trial. The Australian and New Zealand Journal of Psychiatry. 4867417709357. PMID 28578592 DOI: 10.1177/0004867417709357 |
0.462 |
|
| 2017 |
Ratheesh A, Davey CG, Daglas R, Macneil C, Hasty M, Filia K, McGorry PD, Berk M, Conus P, Cotton S. Social and academic premorbid adjustment domains predict different functional outcomes among youth with first episode mania. Journal of Affective Disorders. 219: 133-140. PMID 28550765 DOI: 10.1016/J.Jad.2017.05.030 |
0.311 |
|
| 2017 |
Morris G, Berk M, Puri BK. A Comparison of Neuroimaging Abnormalities in Multiple Sclerosis, Major Depression and Chronic Fatigue Syndrome (Myalgic Encephalomyelitis): is There a Common Cause? Molecular Neurobiology. PMID 28516431 DOI: 10.1007/S12035-017-0598-Z |
0.346 |
|
| 2017 |
Bortolato B, Köhler CA, Evangelou E, León-Caballero J, Solmi M, Stubbs B, Belbasis L, Pacchiarotti I, Kessing LV, Berk M, Vieta E, Carvalho AF. Systematic assessment of environmental risk factors for bipolar disorder: an umbrella review of systematic reviews and meta-analyses. Bipolar Disorders. PMID 28470927 DOI: 10.1111/Bdi.12490 |
0.317 |
|
| 2017 |
Berk L, Hallam KT, Venugopal K, Lewis AJ, Austin DW, Kulkarni J, Dodd S, de Castella A, Fitzgerald PB, Berk M. Impact of irritability: a 2-year observational study of outpatients with bipolar I or schizoaffective disorder. Bipolar Disorders. PMID 28470892 DOI: 10.1111/Bdi.12486 |
0.415 |
|
| 2017 |
Skvarc DR, Dean OM, Byrne LK, Gray L, Lane S, Lewis M, Fernandes BS, Berk M, Marriott A. The effect of N-acetylcysteine (NAC) on human cognition - a systematic review. Neuroscience and Biobehavioral Reviews. PMID 28438466 DOI: 10.1016/J.Neubiorev.2017.04.013 |
0.329 |
|
| 2017 |
Ryan A, Baker A, Dark F, Foley S, Gordon A, Hatherill S, Stathis S, Saha S, Bruxner G, Beckman M, Richardson D, Berk M, Dean O, McGrath J, Group CW, et al. The efficacy of sodium benzoate as an adjunctive treatment in early psychosis - CADENCE-BZ: study protocol for a randomized controlled trial. Trials. 18: 165. PMID 28388932 DOI: 10.1186/S13063-017-1908-5 |
0.387 |
|
| 2017 |
Salagre E, Vizuete AF, Leite M, Brownstein DJ, McGuinness A, Jacka F, Dodd S, Stubbs B, Köhler CA, Vieta E, Carvalho AF, Berk M, Fernandes BS. Homocysteine as a peripheral biomarker in bipolar disorder: A meta-analysis. European Psychiatry : the Journal of the Association of European Psychiatrists. 43: 81-91. PMID 28371745 DOI: 10.1016/J.Eurpsy.2017.02.482 |
0.401 |
|
| 2017 |
Conell J, Bauer R, Glenn T, Alda M, Ardau R, Baune BT, Berk M, Bersudsky Y, Bilderbeck A, Bocchetta A, Bossini L, Paredes Castro AM, Cheung EY, Chillotti C, Choppin S, et al. Erratum to: Online information seeking by patients with bipolar disorder: results from an international multisite survey. International Journal of Bipolar Disorders. 5: 18. PMID 28364388 DOI: 10.1186/S40345-017-0082-8 |
0.352 |
|
| 2017 |
Hasebe K, Gray L, Bortolasci C, Panizzutti B, Mohebbi M, Kidnapillai S, Spolding B, Walder K, Berk M, Malhi G, Dodd S, Dean OM. Adjunctive N-acetylcysteine in depression: exploration of interleukin-6, C-reactive protein and brain-derived neurotrophic factor. Acta Neuropsychiatrica. 1-10. PMID 28318471 DOI: 10.1017/Neu.2017.2 |
0.351 |
|
| 2017 |
Köhler-Forsberg O, Gasse C, Berk M, Østergaard SD. Do Statins Have Antidepressant Effects? Cns Drugs. PMID 28303466 DOI: 10.1007/S40263-017-0422-3 |
0.346 |
|
| 2017 |
Lauder S, Cosgrove VE, Gliddon E, Grimm D, Dodd S, Berk L, Castle D, Suppes TS, Berk M. Progressing MoodSwings. The upgrade and evaluation of MoodSwings 2.0: An online intervention for bipolar disorder. Contemporary Clinical Trials. PMID 28257919 DOI: 10.1016/J.Cct.2017.02.008 |
0.361 |
|
| 2017 |
Berk M, Daglas R, Dandash O, Yücel M, Henry L, Hallam K, Macneil C, Hasty M, Pantelis C, Murphy BP, Kader L, Damodaran S, Wong MT, Conus P, Ratheesh A, et al. Quetiapine v. lithium in the maintenance phase following a first episode of mania: randomised controlled trial. The British Journal of Psychiatry : the Journal of Mental Science. PMID 28254958 DOI: 10.1192/Bjp.Bp.116.186833 |
0.394 |
|
| 2017 |
Chandrasekaran V, Brennan-Olsen SL, Stuart AL, Pasco JA, Berk M, Hodge JM, Williams LJ. Association between bipolar spectrum disorder and bone health: a meta-analysis and systematic review protocol. Bmj Open. 7: e013981. PMID 28246138 DOI: 10.1136/Bmjopen-2016-013981 |
0.353 |
|
| 2017 |
Chatterton ML, Stockings E, Berk M, Barendregt JJ, Carter R, Mihalopoulos C. Psychosocial therapies for the adjunctive treatment of bipolar disorder in adults: network meta-analysis. The British Journal of Psychiatry : the Journal of Mental Science. PMID 28209591 DOI: 10.1192/Bjp.Bp.116.195321 |
0.43 |
|
| 2017 |
Berk M, Berk L. Cognition in psychiatric disorders: from models to management. The Lancet. Psychiatry. PMID 28185901 DOI: 10.1016/S2215-0366(17)30040-8 |
0.313 |
|
| 2017 |
Jacka FN, O'Neil A, Opie R, Itsiopoulos C, Cotton S, Mohebbi M, Castle D, Dash S, Mihalopoulos C, Chatterton ML, Brazionis L, Dean OM, Hodge AM, Berk M. A randomised controlled trial of dietary improvement for adults with major depression (the 'SMILES' trial). Bmc Medicine. 15: 23. PMID 28137247 DOI: 10.1186/S12916-017-0791-Y |
0.38 |
|
| 2017 |
Murray G, Leitan ND, Thomas N, Michalak EE, Johnson SL, Jones S, Perich T, Berk L, Berk M. Towards recovery-oriented psychosocial interventions for bipolar disorder: Quality of life outcomes, stage-sensitive treatments, and mindfulness mechanisms. Clinical Psychology Review. 52: 148-163. PMID 28129636 DOI: 10.1016/J.Cpr.2017.01.002 |
0.354 |
|
| 2017 |
Berk M, Dandash O, Daglas R, Cotton SM, Allott K, Fornito A, Suo C, Klauser P, Liberg B, Henry L, Macneil C, Hasty M, McGorry P, Pantelis C, Yücel M. Neuroprotection after a first episode of mania: a randomized controlled maintenance trial comparing the effects of lithium and quetiapine on grey and white matter volume. Translational Psychiatry. 7: e1011. PMID 28117843 DOI: 10.1038/Tp.2016.281 |
0.333 |
|
| 2017 |
Ratheesh A, Davey C, Hetrick S, Alvarez-Jimenez M, Voutier C, Bechdolf A, McGorry PD, Scott J, Berk M, Cotton SM. A systematic review and meta-analysis of prospective transition from major depression to bipolar disorder. Acta Psychiatrica Scandinavica. PMID 28097648 DOI: 10.1111/Acps.12686 |
0.467 |
|
| 2017 |
Morris G, Walder K, McGee SL, Dean OM, Tye SJ, Maes M, Berk M. A model of the mitochondrial basis of bipolar disorder. Neuroscience and Biobehavioral Reviews. 74: 1-20. PMID 28093238 DOI: 10.1016/J.Neubiorev.2017.01.014 |
0.408 |
|
| 2017 |
Scaini G, Fries G, Valvassori S, Zeni C, Zunta-Soares G, Berk M, Soares J, Quevedo J. Comparative risks of treatment failure in bipolar 1 disorder : a population based study of lithium, valproate, olanzapine, quetiapine and aripiprazole in post mania relapse prevention Bipolar Disorders. 19: 100-101. DOI: 10.1111/Bdi.12480 |
0.383 |
|
| 2017 |
Fernandes BS, Berk M. 980. Insulin is a State Biomarker in Major Depressive Disorder: A Systematic Review and Meta-Analysis Biological Psychiatry. 81. DOI: 10.1016/J.Biopsych.2017.02.706 |
0.397 |
|
| 2017 |
Scaini G, Fries G, Valvassori S, Zeni C, Zunta-Soares G, Berk M, Soares J, Quevedo J. 508. Perturbations in the Apoptotic Pathway and Mitochondrial Network Dynamics in Peripheral Blood Mononuclear Cells from Bipolar Disorder Patients Biological Psychiatry. 81: S206-S207. DOI: 10.1016/J.Biopsych.2017.02.1116 |
0.306 |
|
| 2017 |
Menon R, Cribb L, Murphy J, Ashton MM, Oliver G, Dowling N, Turner A, Dean O, Berk M, Ng CH, Sarris J. Mitochondrial modifying nutrients in treating chronic fatigue syndrome: A 16-week open-label pilot study Advances in Integrative Medicine. 4: 109-114. DOI: 10.1016/J.Aimed.2017.11.001 |
0.31 |
|
| 2016 |
Dipnall JF, Pasco JA, Berk M, Williams LJ, Dodd S, Jacka FN, Meyer D. Into the Bowels of Depression: Unravelling Medical Symptoms Associated with Depression by Applying Machine-Learning Techniques to a Community Based Population Sample. Plos One. 11: e0167055. PMID 27935995 DOI: 10.1371/Journal.Pone.0167055 |
0.34 |
|
| 2016 |
Slyepchenko A, Maes M, Jacka FN, Köhler CA, Barichello T, McIntyre RS, Berk M, Grande I, Foster JA, Vieta E, Carvalho AF. Gut Microbiota, Bacterial Translocation, and Interactions with Diet: Pathophysiological Links between Major Depressive Disorder and Non-Communicable Medical Comorbidities. Psychotherapy and Psychosomatics. 86: 31-46. PMID 27884012 DOI: 10.1159/000448957 |
0.393 |
|
| 2016 |
Fernandes BS, Steiner J, Molendijk ML, Dodd S, Nardin P, Gonçalves CA, Jacka F, Köhler CA, Karmakar C, Carvalho AF, Berk M. C-reactive protein concentrations across the mood spectrum in bipolar disorder: a systematic review and meta-analysis. The Lancet. Psychiatry. PMID 27838212 DOI: 10.1016/S2215-0366(16)30370-4 |
0.365 |
|
| 2016 |
Dipnall JF, Pasco JA, Berk M, Williams LJ, Dodd S, Jacka FN, Meyer D. Why so GLUMM? Detecting depression clusters through graphing lifestyle-environs using machine-learning methods (GLUMM). European Psychiatry : the Journal of the Association of European Psychiatrists. 39: 40-50. PMID 27810617 DOI: 10.1016/J.Eurpsy.2016.06.003 |
0.301 |
|
| 2016 |
Barbé-Tuana FM, Parisi MM, Panizzutti BS, Fries GR, Grun LK, Guma FT, Kapczinski F, Berk M, Gama CS, Rosa AR. Shortened telomere length in bipolar disorder: a comparison of the early and late stages of disease. Revista Brasileira De Psiquiatria (Sao Paulo, Brazil : 1999). 0. PMID 27798713 DOI: 10.1590/1516-4446-2016-1910 |
0.365 |
|
| 2016 |
Leboyer M, Berk M, Yolken RH, Tamouza R, Kupfer D, Groc L. Immuno-psychiatry: an agenda for clinical practice and innovative research. Bmc Medicine. 14: 173. PMID 27788673 DOI: 10.1186/S12916-016-0712-5 |
0.396 |
|
| 2016 |
Bousman CA, Müller DJ, Ng CH, Byron K, Berk M, Singh AB. Concordance between actual and pharmacogenetic predicted desvenlafaxine dose needed to achieve remission in major depressive disorder: a 10-week open-label study. Pharmacogenetics and Genomics. PMID 27779571 DOI: 10.1097/Fpc.0000000000000253 |
0.374 |
|
| 2016 |
Sands N, Elsom S, Corbett R, Keppich-Arnold S, Prematunga R, Berk M, Considine J. Predictors for clinical deterioration of mental state in patients assessed by telephone-based mental health triage. International Journal of Mental Health Nursing. PMID 27779363 DOI: 10.1111/Inm.12267 |
0.32 |
|
| 2016 |
Oedegaard CH, Berk L, Berk M, Youngstrom EA, Dilsaver SC, Belmaker RH, Oedegaard KJ, Fasmer OB, Engebretsen IM. An ISBD perspective on the sociocultural challenges of managing bipolar disorder: A content analysis. The Australian and New Zealand Journal of Psychiatry. PMID 27742913 DOI: 10.1177/0004867416668790 |
0.351 |
|
| 2016 |
Slyepchenko A, Maes M, Machado-Veira R, Anderson G, Solmi M, Sanz Y, Berk M, Köhler CA, Carvalho AF. Intestinal dysbiosis, gut hyperpermeability and bacterial translocation: missing links between depression, obesity and type 2 diabetes? Current Pharmaceutical Design. PMID 27669970 DOI: 10.2174/1381612822666160922165706 |
0.316 |
|
| 2016 |
Sylvia LG, Salcedo S, Peters AT, Magalhães PV, Frank E, Miklowitz DJ, Otto MW, Berk M, Nierenberg AA, Deckersbach T. Do Sleep Disturbances Predict or Moderate the Response to Psychotherapy in Bipolar Disorder? The Journal of Nervous and Mental Disease. PMID 27660995 DOI: 10.1097/Nmd.0000000000000579 |
0.318 |
|
| 2016 |
Rossell SL, Francis PS, Galletly C, Harris A, Siskind D, Berk M, Bozaoglu K, Dark F, Dean O, Liu D, Meyer D, Neill E, Phillipou A, Sarris J, Castle DJ. N-acetylcysteine (NAC) in schizophrenia resistant to clozapine: a double blind randomised placebo controlled trial targeting negative symptoms. Bmc Psychiatry. 16: 320. PMID 27629871 DOI: 10.1186/S12888-016-1030-3 |
0.307 |
|
| 2016 |
Berk M, Tye S, Walder K, McGee S. Hyperthermia for Major Depressive Disorder? Jama Psychiatry. PMID 27627184 DOI: 10.1001/Jamapsychiatry.2016.1532 |
0.442 |
|
| 2016 |
Data-Franco J, Singh A, Popovic D, Ashton M, Berk M, Vieta E, Figueira ML, Dean OM. Beyond the therapeutic shackles of the monoamines: New mechanisms in bipolar disorder biology. Progress in Neuro-Psychopharmacology & Biological Psychiatry. PMID 27616052 DOI: 10.1016/J.Pnpbp.2016.09.004 |
0.364 |
|
| 2016 |
Vieta E, Berk M, Birmaher B, Grande I. Bipolar disorder: defining symptoms and comorbidities - Authors' reply. Lancet (London, England). 388: 869-70. PMID 27597464 DOI: 10.1016/S0140-6736(16)30966-7 |
0.382 |
|
| 2016 |
Berk M, Woods RL, Nelson MR, Shah RC, Reid CM, Storey E, Fitzgerald SM, Lockery JE, Wolfe R, Mohebbi M, Murray AM, Kirpach B, Grimm R, McNeil JJ. ASPREE-D: Aspirin for the prevention of depression in the elderly. International Psychogeriatrics / Ipa. 1-8. PMID 27587328 DOI: 10.1017/S104161021600079X |
0.376 |
|
| 2016 |
Conell J, Bauer R, Glenn T, Alda M, Ardau R, Baune BT, Berk M, Bersudsky Y, Bilderbeck A, Bocchetta A, Bossini L, Paredes Castro AM, Cheung EY, Chillotti C, Choppin S, et al. Online information seeking by patients with bipolar disorder: results from an international multisite survey. International Journal of Bipolar Disorders. 4: 17. PMID 27552813 DOI: 10.1186/S40345-016-0058-0 |
0.352 |
|
| 2016 |
Bauer R, Conell J, Glenn T, Alda M, Ardau R, Baune BT, Berk M, Bersudsky Y, Bilderbeck A, Bocchetta A, Bossini L, Castro AM, Cheung EY, Chillotti C, Choppin S, et al. Internet use by patients with bipolar disorder: Results from an international multisite survey. Psychiatry Research. 242: 388-394. PMID 27391371 DOI: 10.1016/J.Psychres.2016.05.055 |
0.354 |
|
| 2016 |
Kay-Lambkin FJ, Thornton L, Lappin JM, Hanstock T, Sylvia L, Jacka F, Baker AL, Berk M, Mitchell PB, Callister R, Rogers N, Webster S, Dennis S, Oldmeadow C, MacKinnon A, et al. Study protocol for a systematic review of evidence for lifestyle interventions targeting smoking, sleep, alcohol/other drug use, physical activity, and healthy diet in people with bipolar disorder. Systematic Reviews. 5: 106. PMID 27381332 DOI: 10.1186/S13643-016-0282-9 |
0.34 |
|
| 2016 |
Morris G, Berk M, Klein H, Walder K, Galecki P, Maes M. Nitrosative Stress, Hypernitrosylation, and Autoimmune Responses to Nitrosylated Proteins: New Pathways in Neuroprogressive Disorders Including Depression and Chronic Fatigue Syndrome. Molecular Neurobiology. PMID 27339878 DOI: 10.1007/S12035-016-9975-2 |
0.315 |
|
| 2016 |
Dean OM, Gray KM, Villagonzalo KA, Dodd S, Mohebbi M, Vick T, Tonge BJ, Berk M. A randomised, double blind, placebo-controlled trial of a fixed dose of N-acetyl cysteine in children with autistic disorder. The Australian and New Zealand Journal of Psychiatry. PMID 27316706 DOI: 10.1177/0004867416652735 |
0.372 |
|
| 2016 |
Deckersbach T, Peters AT, Sylvia LG, Gold AK, da Silva Magalhaes PV, Henry DB, Frank E, Otto MW, Berk M, Dougherty DD, Nierenberg AA, Miklowitz DJ. A cluster analytic approach to identifying predictors and moderators of psychosocial treatment for bipolar depression: Results from STEP-BD. Journal of Affective Disorders. 203: 152-157. PMID 27289316 DOI: 10.1016/J.Jad.2016.03.064 |
0.395 |
|
| 2016 |
Quirk SE, Berk M, Pasco JA, Brennan-Olsen SL, Chanen AM, Koivumaa-Honkanen H, Burke LM, Jackson HJ, Hulbert C, A Olsson C, Moran P, Stuart AL, Williams LJ. The prevalence, age distribution and comorbidity of personality disorders in Australian women. The Australian and New Zealand Journal of Psychiatry. PMID 27245936 DOI: 10.1177/0004867416649032 |
0.319 |
|
| 2016 |
Williams LJ, Pasco JA, Kessing LV, Quirk SE, Fernandes BS, Berk M. Angiotensin Converting Enzyme Inhibitors and Risk of Mood Disorders. Psychotherapy and Psychosomatics. 85: 250-2. PMID 27230871 DOI: 10.1159/000444646 |
0.309 |
|
| 2016 |
Carvalho AF, Köhler CA, Fernandes BS, Quevedo J, Miskowiak KW, Brunoni AR, Machado-Vieira R, Maes M, Vieta E, Berk M. Bias in emerging biomarkers for bipolar disorder. Psychological Medicine. 1-11. PMID 27193198 DOI: 10.1017/S0033291716000957 |
0.381 |
|
| 2016 |
Salagre E, Fernandes BS, Dodd S, Brownstein DJ, Berk M. Statins for the treatment of depression: A meta-analysis of randomized, double-blind, placebo-controlled trials. Journal of Affective Disorders. 200: 235-242. PMID 27148902 DOI: 10.1016/J.Jad.2016.04.047 |
0.38 |
|
| 2016 |
Chanen AM, Berk M, Thompson K. Integrating Early Intervention for Borderline Personality Disorder and Mood Disorders. Harvard Review of Psychiatry. PMID 27144298 DOI: 10.1097/Hrp.0000000000000105 |
0.386 |
|
| 2016 |
Fernandes BS, Dean OM, Dodd S, Malhi GS, Berk M. N-Acetylcysteine in depressive symptoms and functionality: a systematic review and meta-analysis. The Journal of Clinical Psychiatry. 77: e457-66. PMID 27137430 DOI: 10.4088/Jcp.15R09984 |
0.355 |
|
| 2016 |
Sarris J, Murphy J, Mischoulon D, Papakostas GI, Fava M, Berk M, Ng CH. Adjunctive Nutraceuticals for Depression: A Systematic Review and Meta-Analyses. The American Journal of Psychiatry. appiajp201615091228. PMID 27113121 DOI: 10.1176/Appi.Ajp.2016.15091228 |
0.36 |
|
| 2016 |
Davis J, Eyre H, Jacka FN, Dodd S, Dean O, McEwen S, Debnath M, McGrath J, Maes M, Amminger P, McGorry PD, Pantelis C, Berk M. A review of vulnerability and risks for schizophrenia: Beyond the two hit hypothesis. Neuroscience and Biobehavioral Reviews. 65: 185-194. PMID 27073049 DOI: 10.1016/J.Neubiorev.2016.03.017 |
0.305 |
|
| 2016 |
Fernandes BS, Dash S, Jacka F, Dodd S, Carvalho AF, Köhler CA, Steiner J, da Graça Cantarelli M, Nardin P, Gonçalves CA, Berk M. Leptin in bipolar disorder: A systematic review and meta-analysis. European Psychiatry : the Journal of the Association of European Psychiatrists. 35: 1-7. PMID 27065008 DOI: 10.1016/J.Eurpsy.2016.02.003 |
0.375 |
|
| 2016 |
Ratheesh A, Cotton SM, Davey CG, Adams S, Bechdolf A, Macneil C, Berk M, McGorry PD. Ethical considerations in preventive interventions for bipolar disorder. Early Intervention in Psychiatry. PMID 27027848 DOI: 10.1111/Eip.12340 |
0.363 |
|
| 2016 |
Rosenblat JD, Kakar R, Berk M, Kessing LV, Vinberg M, Baune BT, Mansur RB, Brietzke E, Goldstein BI, McIntyre RS. Anti-inflammatory agents in the treatment of bipolar depression: a systematic review and meta-analysis. Bipolar Disorders. PMID 26990051 DOI: 10.1111/Bdi.12373 |
0.439 |
|
| 2016 |
Quirk SE, Stuart AL, Brennan-Olsen SL, Pasco JA, Berk M, Chanen AM, Koivumaa-Honkanen H, Kotowicz MA, Lukkala PS, Williams LJ. Physical health comorbidities in women with personality disorder: Data from the Geelong Osteoporosis Study. European Psychiatry : the Journal of the Association of European Psychiatrists. 34: 29-35. PMID 26928343 DOI: 10.1016/J.Eurpsy.2015.12.007 |
0.313 |
|
| 2016 |
O'Neil A, Fisher AJ, Kibbey KJ, Jacka FN, Kotowicz MA, Williams LJ, Stuart AL, Berk M, Lewandowski PA, Taylor CB, Pasco JA. Depression is a risk factor for incident coronary heart disease in women: An 18-year longitudinal study. Journal of Affective Disorders. 196: 117-124. PMID 26921864 DOI: 10.1016/J.Jad.2016.02.029 |
0.335 |
|
| 2016 |
O'Neil A, Fisher AJ, Kibbey K, Jacka FN, Kotowicz MA, Williams LJ, Stuart AL, Berk M, Lewandowski PA, Atherton JJ, Taylor CB, Pasco JA. The addition of depression to the Framingham Risk Equation model for predicting coronary heart disease risk in women. Preventive Medicine. PMID 26906397 DOI: 10.1016/J.Ypmed.2016.02.028 |
0.302 |
|
| 2016 |
Slyepchenko A, Maes M, Köhler CA, Anderson G, Quevedo J, Alves GS, Berk M, Fernandes BS, Carvalho AF. T helper 17 cells may drive neuroprogression in major depressive disorder: Proposal of an integrative model. Neuroscience and Biobehavioral Reviews. PMID 26898639 DOI: 10.1016/J.Neubiorev.2016.02.002 |
0.379 |
|
| 2016 |
Oldis M, Murray G, Macneil CA, Hasty MK, Daglas R, Berk M, Conus P, Cotton SM. Trajectory and predictors of quality of life in first episode psychotic mania. Journal of Affective Disorders. 195: 148-155. PMID 26896807 DOI: 10.1016/J.Jad.2016.02.018 |
0.383 |
|
| 2016 |
Berger GE, Smesny S, Schäfer MR, Milleit B, Langbein K, Hipler UC, Milleit C, Klier CM, Schlögelhofer M, Holub M, Holzer I, Berk M, McGorry PD, Sauer H, Amminger GP. Niacin Skin Sensitivity Is Increased in Adolescents at Ultra-High Risk for Psychosis. Plos One. 11: e0148429. PMID 26894921 DOI: 10.1371/Journal.Pone.0148429 |
0.304 |
|
| 2016 |
Dipnall JF, Pasco JA, Berk M, Williams LJ, Dodd S, Jacka FN, Meyer D. Fusing Data Mining, Machine Learning and Traditional Statistics to Detect Biomarkers Associated with Depression. Plos One. 11: e0148195. PMID 26848571 DOI: 10.1371/Journal.Pone.0148195 |
0.319 |
|
| 2016 |
Williams LJ, Pasco JA, Mohebbi M, Jacka FN, Stuart AL, Venugopal K, O'Neil A, Berk M. Statin And Aspirin Use And The Risk Of Mood Disorders Among Men. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). PMID 26839250 DOI: 10.1093/Ijnp/Pyw008 |
0.402 |
|
| 2016 |
Bortolato B, Berk M, Maes M, McIntyre RSMRS, Carvalho AF. Fibromyalgia and Bipolar Disorder: Emerging Epidemiological Associations and Shared Pathophysiology Current Molecular Medicine. 16: 119-136. PMID 26812920 DOI: 10.2174/1566524016666160126144027 |
0.418 |
|
| 2016 |
Carvalho AF, Köhler CA, Brunoni AR, Miskowiak KW, Herrmann N, Lanctôt KL, Hyphantis TN, Quevedo J, Fernandes BS, Berk M. Bias in Peripheral Depression Biomarkers. Psychotherapy and Psychosomatics. 85: 81-90. PMID 26808272 DOI: 10.1159/000441457 |
0.409 |
|
| 2016 |
Bortolato B, Miskowiak KW, Köhler CA, Maes M, Fernandes BS, Berk M, Carvalho AF. Cognitive remission: a novel objective for the treatment of major depression? Bmc Medicine. 14: 9. PMID 26801406 DOI: 10.1186/S12916-016-0560-3 |
0.368 |
|
| 2016 |
Stange JP, Sylvia LG, da Silva Magalhães PV, Miklowitz DJ, Otto MW, Frank E, Yim C, Berk M, Dougherty DD, Nierenberg AA, Deckersbach T. Affective instability and the course of bipolar depression: results from the STEP-BD randomised controlled trial of psychosocial treatment. The British Journal of Psychiatry : the Journal of Mental Science. PMID 26795426 DOI: 10.1192/Bjp.Bp.114.162073 |
0.428 |
|
| 2016 |
Stange JP, Kleiman EM, Sylvia LG, Magalhães PV, Berk M, Nierenberg AA, Deckersbach T. SPECIFIC MOOD SYMPTOMS CONFER RISK FOR SUBSEQUENT SUICIDAL IDEATION IN BIPOLAR DISORDER WITH AND WITHOUT SUICIDE ATTEMPT HISTORY: MULTI-WAVE DATA FROM STEP-BD. Depression and Anxiety. PMID 26756163 DOI: 10.1002/Da.22464 |
0.375 |
|
| 2016 |
Passos IC, Mwangi B, Vieta E, Berk M, Kapczinski F. Areas of controversy in neuroprogression in bipolar disorder Acta Psychiatrica Scandinavica. DOI: 10.1111/Acps.12581 |
0.396 |
|
| 2015 |
Duong A, Che Y, Ceylan D, Pinguelo A, Andreazza AC, Trevor Young L, Berk M. Regulators of mitochondrial complex I activity: A review of literature and evaluation in postmortem prefrontal cortex from patients with bipolar disorder. Psychiatry Research. PMID 26723136 DOI: 10.1016/J.Psychres.2015.12.015 |
0.319 |
|
| 2015 |
Williams LJ, Pasco JA, Jackson H, Kiropoulos L, Stuart AL, Jacka FN, Berk M. Depression as a risk factor for fracture in women: A 10 year longitudinal study. Journal of Affective Disorders. 192: 34-40. PMID 26706830 DOI: 10.1016/J.Jad.2015.11.048 |
0.342 |
|
| 2015 |
Daglas R, Cotton SM, Allott K, Yücel M, Macneil CA, Hasty MK, Murphy B, Pantelis C, Hallam KT, Henry LP, Conus P, Ratheesh A, Kader L, Wong MT, McGorry PD, ... Berk M, et al. A single-blind, randomised controlled trial on the effects of lithium and quetiapine monotherapy on the trajectory of cognitive functioning in first episode mania: A 12-month follow-up study. European Psychiatry : the Journal of the Association of European Psychiatrists. 31: 20-28. PMID 26655594 DOI: 10.1016/J.Eurpsy.2015.09.460 |
0.328 |
|
| 2015 |
Bora E, Berk M. Theory of mind in major depressive disorder: A meta-analysis. Journal of Affective Disorders. 191: 49-55. PMID 26655114 DOI: 10.1016/J.Jad.2015.11.023 |
0.393 |
|
| 2015 |
Aggarwal S, Berk M, Taljard L, Wilson Z. South African adolescents' beliefs about depression. The International Journal of Social Psychiatry. PMID 26634897 DOI: 10.1177/0020764015618226 |
0.36 |
|
| 2015 |
Fernandes BS, Molendijk ML, Köhler CA, Soares JC, Leite CM, Machado-Vieira R, Ribeiro TL, Silva JC, Sales PM, Quevedo J, Oertel-Knöchel V, Vieta E, González-Pinto A, Berk M, Carvalho AF. Peripheral brain-derived neurotrophic factor (BDNF) as a biomarker in bipolar disorder: a meta-analysis of 52 studies. Bmc Medicine. 13: 289. PMID 26621529 DOI: 10.1186/S12916-015-0529-7 |
0.377 |
|
| 2015 |
Peters AT, Shesler LW, Sylvia L, da Silva Magalhaes PV, Miklowitz DJ, Otto MW, Frank E, Berk M, Dougherty DD, Nierenberg AA, Deckersbach T. Medical burden, body mass index and the outcome of psychosocial interventions for bipolar depression. The Australian and New Zealand Journal of Psychiatry. PMID 26590023 DOI: 10.1177/0004867415616694 |
0.389 |
|
| 2015 |
Fernandes BS, Hodge JM, Pasco JA, Berk M, Williams LJ. Effects of Depression and Serotonergic Antidepressants on Bone: Mechanisms and Implications for the Treatment of Depression. Drugs & Aging. PMID 26547857 DOI: 10.1007/S40266-015-0323-4 |
0.387 |
|
| 2015 |
Williams LJ, Jacka FN, Pasco JA, Coulson CE, Quirk SE, Stuart AL, Berk M. The prevalence and age of onset of psychiatric disorders in Australian men. The Australian and New Zealand Journal of Psychiatry. PMID 26546500 DOI: 10.1177/0004867415614105 |
0.386 |
|
| 2015 |
Quinn AL, Dean OM, Davey CG, Kerr M, Harrigan SM, Cotton SM, Chanen AM, Dodd S, Ratheesh A, Amminger GP, Phelan M, Williams A, Mackinnon A, Giorlando F, Baird S, ... ... Berk M, et al. Youth Depression Alleviation-Augmentation with an anti-inflammatory agent (YoDA-A): protocol and rationale for a placebo-controlled randomized trial of rosuvastatin and aspirin. Early Intervention in Psychiatry. PMID 26542332 DOI: 10.1111/Eip.12280 |
0.777 |
|
| 2015 |
Talarowska M, Berk M, Maes M, Gałecki P. Autobiographical memory dysfunctions in depressive disorders. Psychiatry and Clinical Neurosciences. PMID 26522618 DOI: 10.1111/Pcn.12370 |
0.408 |
|
| 2015 |
Conus P, Berk M, Cotton SM, Kader L, Macneil C, Hasty MK, Hallam K, Lambert M, Murphy BP, McGorry PD. Olanzapine or chlorpromazine plus lithium in first episode psychotic mania: An 8-week randomised controlled trial. European Psychiatry : the Journal of the Association of European Psychiatrists. 30: 975-982. PMID 26485297 DOI: 10.1016/J.Eurpsy.2015.09.009 |
0.365 |
|
| 2015 |
Gliddon E, Lauder S, Berk L, Cosgrove V, Grimm D, Dodd S, Suppes T, Berk M. Evaluating discussion board engagement in the MoodSwings online self-help program for bipolar disorder: protocol for an observational prospective cohort study. Bmc Psychiatry. 15: 243. PMID 26462799 DOI: 10.1186/S12888-015-0630-7 |
0.329 |
|
| 2015 |
Stuart AL, Pasco JA, Jacka FN, Berk M, Williams LJ. Falls and Depression in Men: A Population-Based Study. American Journal of Men's Health. PMID 26438469 DOI: 10.1177/1557988315609111 |
0.372 |
|
| 2015 |
Pasco JA, Williams LJ, Brennan-Olsen SL, Berk M, Jacka FN. Milk Consumption and the Risk for Incident Major Depressive Disorder. Psychotherapy and Psychosomatics. 84: 384-6. PMID 26402222 DOI: 10.1159/000381831 |
0.413 |
|
| 2015 |
Grande I, Berk M, Birmaher B, Vieta E. Bipolar disorder. Lancet (London, England). PMID 26388529 DOI: 10.1016/S0140-6736(15)00241-X |
0.335 |
|
| 2015 |
Sarris J, Oliver G, Camfield DA, Dean OM, Dowling N, Smith DJ, Murphy J, Menon R, Berk M, Blair-West S, Ng CH. N-Acetyl Cysteine (NAC) in the Treatment of Obsessive-Compulsive Disorder: A 16-Week, Double-Blind, Randomised, Placebo-Controlled Study. Cns Drugs. 29: 801-9. PMID 26374743 DOI: 10.1007/S40263-015-0272-9 |
0.365 |
|
| 2015 |
Quirk SE, Williams LJ, Chanen AM, Berk M. Personality disorder and population mental health. The Lancet. Psychiatry. 2: 201-2. PMID 26359889 DOI: 10.1016/S2215-0366(14)00144-8 |
0.315 |
|
| 2015 |
Malhi GS, Berk M. Depolarising bipolarity: Clinical considerations. The Australian and New Zealand Journal of Psychiatry. 49: 767-9. PMID 26310795 DOI: 10.1177/0004867415602559 |
0.316 |
|
| 2015 |
Martin-Subero M, Anderson G, Kanchanatawan B, Berk M, Maes M. Comorbidity between depression and inflammatory bowel disease explained by immune-inflammatory, oxidative, and nitrosative stress; tryptophan catabolite; and gut-brain pathways. Cns Spectrums. 1-15. PMID 26307347 DOI: 10.1017/S1092852915000449 |
0.37 |
|
| 2015 |
Kim SW, Bae KY, Kim JM, Shin IS, Hong YJ, Ahn Y, Jeong MH, Berk M, Yoon JS. The use of statins for the treatment of depression in patients with acute coronary syndrome. Translational Psychiatry. 5: e620. PMID 26285130 DOI: 10.1038/Tp.2015.116 |
0.392 |
|
| 2015 |
Pasco JA, Williams LJ, Jacka FN, Stupka N, Brennan-Olsen SL, Holloway KL, Berk M. Sarcopenia and the Common Mental Disorders: a Potential Regulatory Role of Skeletal Muscle on Brain Function? Current Osteoporosis Reports. 13: 351-7. PMID 26228522 DOI: 10.1007/S11914-015-0279-7 |
0.302 |
|
| 2015 |
Carvalho AF, Köhler CA, McIntyre RS, Knöchel C, Brunoni AR, Thase ME, Quevedo J, Fernandes BS, Berk M. Peripheral vascular endothelial growth factor as a novel depression biomarker: A meta-analysis. Psychoneuroendocrinology. 62: 18-26. PMID 26210676 DOI: 10.1016/J.Psyneuen.2015.07.002 |
0.348 |
|
| 2015 |
Kim SW, Dodd S, Berk L, Kulkarni J, de Castella A, Fitzgerald PB, Kim JM, Yoon JS, Berk M. Impact of Cannabis Use on Long-Term Remission in Bipolar I and Schizoaffective Disorder. Psychiatry Investigation. 12: 349-55. PMID 26207128 DOI: 10.4306/Pi.2015.12.3.349 |
0.362 |
|
| 2015 |
Hayley AC, Skogen JC, Sivertsen B, Wold B, Berk M, Pasco JA, Øverland S. Symptoms of Depression and Difficulty Initiating Sleep from Early Adolescence to Early Adulthood: A Longitudinal Study. Sleep. 38: 1599-606. PMID 26194578 DOI: 10.5665/Sleep.5056 |
0.352 |
|
| 2015 |
Dodd S, Schacht A, Kelin K, Dueñas H, Reed VA, Williams LJ, Quirk FH, Malhi GS, Berk M. Nocebo effects in the treatment of major depression: results from an individual study participant-level meta-analysis of the placebo arm of duloxetine clinical trials. The Journal of Clinical Psychiatry. 76: 702-11. PMID 26132671 DOI: 10.4088/Jcp.13R08858 |
0.347 |
|
| 2015 |
Waterdrinker A, Berk M, Venugopal K, Rapado-Castro M, Turner A, Dean OM. Effects of N-Acetyl cysteine on suicidal ideation in bipolar depression. The Journal of Clinical Psychiatry. 76: 665. PMID 26035204 DOI: 10.4088/Jcp.14L09378 |
0.366 |
|
| 2015 |
Gałecki P, Talarowska M, Anderson G, Berk M, Maes M. Mechanisms underlying neurocognitive dysfunctions in recurrent major depression. Medical Science Monitor : International Medical Journal of Experimental and Clinical Research. 21: 1535-47. PMID 26017336 DOI: 10.12659/Msm.893176 |
0.363 |
|
| 2015 |
Ratheesh A, Cotton SM, Betts JK, Chanen A, Nelson B, Davey CG, McGorry PD, Berk M, Bechdolf A. Prospective progression from high-prevalence disorders to bipolar disorder: Exploring characteristics of pre-illness stages. Journal of Affective Disorders. 183: 45-8. PMID 26001662 DOI: 10.1016/J.Jad.2015.04.025 |
0.447 |
|
| 2015 |
Deepmala, Slattery J, Kumar N, Delhey L, Berk M, Dean O, Spielholz C, Frye R. Clinical trials of N-acetylcysteine in psychiatry and neurology: A systematic review. Neuroscience and Biobehavioral Reviews. 55: 294-321. PMID 25957927 DOI: 10.1016/J.Neubiorev.2015.04.015 |
0.428 |
|
| 2015 |
Maes M, Nowak G, Caso JR, Leza JC, Song C, Kubera M, Klein H, Galecki P, Noto C, Glaab E, Balling R, Berk M. Toward Omics-Based, Systems Biomedicine, and Path and Drug Discovery Methodologies for Depression-Inflammation Research. Molecular Neurobiology. PMID 25934103 DOI: 10.1007/S12035-015-9183-5 |
0.328 |
|
| 2015 |
Daglas R, Yücel M, Cotton S, Allott K, Hetrick S, Berk M. Cognitive impairment in first-episode mania: a systematic review of the evidence in the acute and remission phases of the illness. International Journal of Bipolar Disorders. 3: 9. PMID 25914866 DOI: 10.1186/S40345-015-0024-2 |
0.333 |
|
| 2015 |
Singh AB, Bousman CA, Ng CH, Byron K, Berk M. Effects of persisting emotional impact from child abuse and norepinephrine transporter genetic variation on antidepressant efficacy in major depression: a pilot study. Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology. 13: 53-61. PMID 25912538 DOI: 10.9758/Cpn.2015.13.1.53 |
0.345 |
|
| 2015 |
Oliver G, Dean O, Camfield D, Blair-West S, Ng C, Berk M, Sarris J. N-acetyl cysteine in the treatment of obsessive compulsive and related disorders: a systematic review. Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology. 13: 12-24. PMID 25912534 DOI: 10.9758/Cpn.2015.13.1.12 |
0.397 |
|
| 2015 |
Thomson D, Berk M, Dodd S, Rapado-Castro M, Quirk SE, Ellegaard PK, Berk L, Dean OM. Tobacco use in bipolar disorder. Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology. 13: 1-11. PMID 25912533 DOI: 10.9758/Cpn.2015.13.1.1 |
0.351 |
|
| 2015 |
Morris G, Berk M. The many roads to mitochondrial dysfunction in neuroimmune and neuropsychiatric disorders. Bmc Medicine. 13: 68. PMID 25889215 DOI: 10.1186/S12916-015-0310-Y |
0.38 |
|
| 2015 |
Williams LJ, Pasco JA, Stuart AL, Jacka FN, Brennan SL, Dobbins AG, Honkanen R, Koivumaa-Honkanen H, Rauma PH, Berk M. Psychiatric disorders, psychotropic medication use and falls among women: an observational study. Bmc Psychiatry. 15: 75. PMID 25884941 DOI: 10.1186/S12888-015-0439-4 |
0.361 |
|
| 2015 |
Ghanizadeh A, Singh AB, Berk M, Torabi-Nami M. Homocysteine as a potential biomarker in bipolar disorders: a critical review and suggestions for improved studies. Expert Opinion On Therapeutic Targets. 19: 927-39. PMID 25882812 DOI: 10.1517/14728222.2015.1019866 |
0.433 |
|
| 2015 |
Talarowska M, Szemraj J, Berk M, Maes M, Ga?ecki P. Oxidant/antioxidant imbalance is an inherent feature of depression. Bmc Psychiatry. 15: 71. PMID 25880127 DOI: 10.1186/S12888-015-0454-5 |
0.376 |
|
| 2015 |
Bortolasci CC, Vargas HO, Vargas Nunes SO, de Melo LG, de Castro MR, Moreira EG, Dodd S, Barbosa DS, Berk M, Maes M. Factors influencing insulin resistance in relation to atherogenicity in mood disorders, the metabolic syndrome and tobacco use disorder. Journal of Affective Disorders. 179: 148-55. PMID 25863911 DOI: 10.1016/J.Jad.2015.03.041 |
0.346 |
|
| 2015 |
Bauer M, Glenn T, Alda M, Andreassen OA, Angelopoulos E, Ardau R, Baethge C, Bauer R, Baune BT, Bellivier F, Belmaker RH, Berk M, Bjella TD, Bossini L, Bersudsky Y, et al. Influence of light exposure during early life on the age of onset of bipolar disorder. Journal of Psychiatric Research. 64: 1-8. PMID 25862378 DOI: 10.1016/J.Jpsychires.2015.03.013 |
0.356 |
|
| 2015 |
Ratheesh A, Berk M, Davey CG, McGorry PD, Cotton SM. Instruments that prospectively predict bipolar disorder - A systematic review. Journal of Affective Disorders. 179: 65-73. PMID 25845751 DOI: 10.1016/J.Jad.2015.03.025 |
0.355 |
|
| 2015 |
Callaly E, Walder K, Morris G, Maes M, Debnath M, Berk M. Mitochondrial dysfunction in the pathophysiology of bipolar disorder: effects of pharmacotherapy. Mini Reviews in Medicinal Chemistry. 15: 355-65. PMID 25807948 DOI: 10.2174/1389557515666150324122026 |
0.382 |
|
| 2015 |
Murray G, Leitan ND, Berk M, Thomas N, Michalak E, Berk L, Johnson SL, Jones S, Perich T, Allen NB, Kyrios M. Online mindfulness-based intervention for late-stage bipolar disorder: pilot evidence for feasibility and effectiveness. Journal of Affective Disorders. 178: 46-51. PMID 25795535 DOI: 10.1016/J.Jad.2015.02.024 |
0.334 |
|
| 2015 |
Thomson D, Turner A, Lauder S, Gigler ME, Berk L, Singh AB, Pasco JA, Berk M, Sylvia L. A brief review of exercise, bipolar disorder, and mechanistic pathways. Frontiers in Psychology. 6: 147. PMID 25788889 DOI: 10.3389/Fpsyg.2015.00147 |
0.394 |
|
| 2015 |
Prado E, Maes M, Piccoli LG, Baracat M, Barbosa DS, Franco O, Dodd S, Berk M, Vargas Nunes SO. N-acetylcysteine for therapy-resistant tobacco use disorder: a pilot study. Redox Report : Communications in Free Radical Research. PMID 25729878 DOI: 10.1179/1351000215Y.0000000004 |
0.377 |
|
| 2015 |
Kim SW, Jeong BO, Kim JM, Shin IS, Hwang MY, Paul Amminger G, Nelson B, Berk M, McGorry P, Yoon JS. Associations of obsessive-compulsive symptoms with clinical and neurocognitive features in schizophrenia according to stage of illness. Psychiatry Research. 226: 368-75. PMID 25681006 DOI: 10.1016/J.Psychres.2015.01.021 |
0.351 |
|
| 2015 |
O'Neil A, Jacka FN, Quirk SE, Cocker F, Taylor CB, Oldenburg B, Berk M. A shared framework for the common mental disorders and Non-Communicable Disease: key considerations for disease prevention and control. Bmc Psychiatry. 15: 15. PMID 25652365 DOI: 10.1186/S12888-015-0394-0 |
0.34 |
|
| 2015 |
Berk M, Tiller JW, Zhao J, Yatham LN, Malhi GS, Weiller E. Effects of asenapine in bipolar I patients meeting proxy criteria for moderate-to-severe mixed major depressive episodes: a post hoc analysis. The Journal of Clinical Psychiatry. 76: 728-34. PMID 25612216 DOI: 10.4088/Jcp.13M08827 |
0.432 |
|
| 2015 |
Morris G, Berk M, Galecki P, Walder K, Maes M. The Neuro-Immune Pathophysiology of Central and Peripheral Fatigue in Systemic Immune-Inflammatory and Neuro-Immune Diseases. Molecular Neurobiology. PMID 25598355 DOI: 10.1007/S12035-015-9090-9 |
0.324 |
|
| 2015 |
Amminger GP, Mechelli A, Rice S, Kim SW, Klier CM, McNamara RK, Berk M, McGorry PD, Schäfer MR. Predictors of treatment response in young people at ultra-high risk for psychosis who received long-chain omega-3 fatty acids. Translational Psychiatry. 5: e495. PMID 25585167 DOI: 10.1038/Tp.2014.134 |
0.312 |
|
| 2015 |
Dipnall JF, Pasco JA, Meyer D, Berk M, Williams LJ, Dodd S, Jacka FN. The association between dietary patterns, diabetes and depression. Journal of Affective Disorders. 174: 215-24. PMID 25527991 DOI: 10.1016/J.Jad.2014.11.030 |
0.339 |
|
| 2015 |
Aggarwal S, Berk M. Evolution of adolescent mental health in a rapidly changing socioeconomic environment: a review of mental health studies in adolescents in India over last 10 years. Asian Journal of Psychiatry. 13: 3-12. PMID 25499463 DOI: 10.1016/J.Ajp.2014.11.007 |
0.318 |
|
| 2015 |
Bauer M, Glenn T, Alda M, Andreassen OA, Angelopoulos E, Ardau R, Baethge C, Bauer R, Bellivier F, Belmaker RH, Berk M, Bjella TD, Bossini L, Bersudsky Y, Cheung EY, et al. Influence of birth cohort on age of onset cluster analysis in bipolar I disorder. European Psychiatry : the Journal of the Association of European Psychiatrists. 30: 99-105. PMID 25498240 DOI: 10.1016/J.Eurpsy.2014.10.005 |
0.313 |
|
| 2015 |
Vargas Nunes SO, Pizzo de Castro MR, Moreira EG, Guembarovski RL, Barbosa DS, Vargas HO, Piccoli de Melo LG, Bortolasci CC, Watanabe MA, Dodd S, Berk M, Maes M. Association of paraoxonase (PON)1 activity, glutathione S-transferase GST T1/M1 and STin.2 polymorphisms with comorbidity of tobacco use disorder and mood disorders. Neuroscience Letters. 585: 132-7. PMID 25445355 DOI: 10.1016/J.Neulet.2014.11.002 |
0.397 |
|
| 2015 |
Dash S, Clarke G, Berk M, Jacka FN. The gut microbiome and diet in psychiatry: focus on depression. Current Opinion in Psychiatry. 28: 1-6. PMID 25415497 DOI: 10.1097/Yco.0000000000000117 |
0.407 |
|
| 2015 |
Rapado-Castro M, Berk M, Venugopal K, Bush AI, Dodd S, Dean OM. Towards stage specific treatments: effects of duration of illness on therapeutic response to adjunctive treatment with N-acetyl cysteine in schizophrenia. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 57: 69-75. PMID 25315856 DOI: 10.1016/J.Pnpbp.2014.10.002 |
0.393 |
|
| 2015 |
Dean OM, Turner A, Malhi GS, Ng C, Cotton SM, Dodd S, Sarris J, Samuni Y, Tanious M, Dowling N, Waterdrinker A, Smith D, Berk M. Design and rationale of a 16-week adjunctive randomized placebo-controlled trial of mitochondrial agents for the treatment of bipolar depression. Revista Brasileira De Psiquiatria (SãO Paulo, Brazil : 1999). 37: 3-12. PMID 25295681 DOI: 10.1590/1516-4446-2013-1341 |
0.486 |
|
| 2015 |
Lauder S, Chester A, Castle D, Dodd S, Gliddon E, Berk L, Chamberlain J, Klein B, Gilbert M, Austin DW, Berk M. A randomized head to head trial of MoodSwings.net.au: an Internet based self-help program for bipolar disorder. Journal of Affective Disorders. 171: 13-21. PMID 25282145 DOI: 10.1016/J.Jad.2014.08.008 |
0.397 |
|
| 2015 |
Leitan ND, Michalak EE, Berk L, Berk M, Murray G. Optimizing delivery of recovery-oriented online self-management strategies for bipolar disorder: a review. Bipolar Disorders. 17: 115-27. PMID 25238632 DOI: 10.1111/Bdi.12258 |
0.305 |
|
| 2015 |
Hayley AC, Williams LJ, Venugopal K, Kennedy GA, Berk M, Pasco JA. The relationships between insomnia, sleep apnoea and depression: findings from the American National Health and Nutrition Examination Survey, 2005-2008. The Australian and New Zealand Journal of Psychiatry. 49: 156-70. PMID 25128225 DOI: 10.1177/0004867414546700 |
0.356 |
|
| 2015 |
Aggarwal S, Dodd S, Berk M. Restless leg syndrome associated with atypical antipsychotics: current status, pathophysiology, and clinical implications. Current Drug Safety. 10: 98-105. PMID 24861990 DOI: 10.2174/1574886309666140527114159 |
0.329 |
|
| 2015 |
Kulkarni J, Gavrilidis E, Wang W, Worsley R, Fitzgerald PB, Gurvich C, Van Rheenen T, Berk M, Burger H. Estradiol for treatment-resistant schizophrenia: a large-scale randomized-controlled trial in women of child-bearing age. Molecular Psychiatry. 20: 695-702. PMID 24732671 DOI: 10.1038/Mp.2014.33 |
0.325 |
|
| 2015 |
Chatterton ML, Mihalopoulos C, Barendregt J, Berk M, Mitchell PB, Khoo J, Carter R. Modelled cost-effectiveness evaluation of bipolar disorder treatments to guide health policy Bipolar Disorders. 17: 52-52. DOI: 10.1111/Bdi.12308 |
0.326 |
|
| 2015 |
Berk M, Daglas R, Yucel M, Dandash O, Cotton SM. Neuroprotection in the aftermath of a first episode of mania European Psychiatry. 30: 85. DOI: 10.1016/S0924-9338(15)30071-7 |
0.315 |
|
| 2015 |
Chatterton ML, Mihalopoulos C, Barendregt J, Berk M, Mitchell PB, Khoo J, Carter R. A Cost-effectiveness model to Guide Health policy in Bipolar Disorder Treatment Value in Health. 18. DOI: 10.1016/J.Jval.2015.03.713 |
0.334 |
|
| 2015 |
Sarris J, Stough C, Bousman C, Murphy J, Savage K, Smith DJ, Menon R, Chamoli S, Oliver G, Berk M, Byrne GJ, Ng C, Mischoulon D. An adjunctive antidepressant nutraceutical combination in treating major depression: Study protocol, And clinical considerations Advances in Integrative Medicine. 2: 49-55. DOI: 10.1016/J.Aimed.2015.02.001 |
0.429 |
|
| 2014 |
Hasty M, Macneil C, Cotton S, Berk M, Conus P. The impact of personality disorder on outcome following a first episode of mania with psychotic features Early Intervention in Psychiatry. 8: 73-73. PMID 30307889 DOI: 10.1111/Eip.12199 |
0.355 |
|
| 2014 |
Dean OM, Maes M, Ashton M, Berk L, Kanchanatawan B, Sughondhabirom A, Tangwongchai S, Ng C, Dowling N, Malhi GS, Berk M. Protocol and Rationale-The Efficacy of Minocycline as an Adjunctive Treatment for Major Depressive Disorder: A Double Blind, Randomised, Placebo Controlled Trial. Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology. 12: 180-188. PMID 25598820 DOI: 10.9758/Cpn.2014.12.3.180 |
0.485 |
|
| 2014 |
Parker G, Paterson A, Fletcher K, McClure G, Berk M. Construct validity of the Experiences of Therapy Questionnaire (ETQ). Bmc Psychiatry. 14: 369. PMID 25551579 DOI: 10.1186/S12888-014-0369-6 |
0.34 |
|
| 2014 |
Carvalho AF, Quevedo J, McIntyre RS, Soeiro-de-Souza MG, Fountoulakis KN, Berk M, Hyphantis TN, Vieta E. Treatment implications of predominant polarity and the polarity index: a comprehensive review. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 18. PMID 25522415 DOI: 10.1093/Ijnp/Pyu079 |
0.383 |
|
| 2014 |
Wang Y, Zhang H, Chai F, Liu X, Berk M. The effects of escitalopram on myocardial apoptosis and the expression of Bax and Bcl-2 during myocardial ischemia/reperfusion in a model of rats with depression. Bmc Psychiatry. 14: 349. PMID 25471226 DOI: 10.1186/S12888-014-0349-X |
0.323 |
|
| 2014 |
Redlich C, Berk M, Williams LJ, Sundquist J, Sundquist K, Li X. Statin use and risk of depression: a Swedish national cohort study. Bmc Psychiatry. 14: 348. PMID 25471121 DOI: 10.1186/S12888-014-0348-Y |
0.38 |
|
| 2014 |
Carvalho AF, Miskowiak KK, Hyphantis TN, Kohler CA, Alves GS, Bortolato B, G Sales PM, Machado-Vieira R, Berk M, McIntyre RS. Cognitive dysfunction in depression - pathophysiology and novel targets. Cns & Neurological Disorders Drug Targets. 13: 1819-35. PMID 25470397 DOI: 10.2174/1871527313666141130203627 |
0.327 |
|
| 2014 |
Pizzo de Castro MR, Vargas Nunes SO, Guembarovski RL, Ariza CB, Oda JM, Vargas HO, Piccoli de Melo LG, Watanabe MA, Berk M, Maes M. STin2 VNTR polymorphism is associated with comorbid tobacco use and mood disorders. Journal of Affective Disorders. 172: 347-354. PMID 25451436 DOI: 10.1016/J.Jad.2014.10.023 |
0.43 |
|
| 2014 |
Sarró S, Madre M, Fernández-Corcuera P, Valentí M, Goikolea JM, Pomarol-Clotet E, Berk M, Amann BL. Transcultural adaption and validation of the Spanish version of the Bipolar Depression Rating Scale (BDRS-S). Journal of Affective Disorders. 172: 110-115. PMID 25451403 DOI: 10.1016/J.Jad.2014.10.009 |
0.387 |
|
| 2014 |
Nunes SO, Piccoli de Melo LG, Pizzo de Castro MR, Barbosa DS, Vargas HO, Berk M, Maes M. Atherogenic index of plasma and atherogenic coefficient are increased in major depression and bipolar disorder, especially when comorbid with tobacco use disorder. Journal of Affective Disorders. 172: 55-62. PMID 25451396 DOI: 10.1016/J.Jad.2014.09.038 |
0.442 |
|
| 2014 |
Mancuso SG, Morgan VA, Mitchell PB, Berk M, Young A, Castle DJ. A comparison of schizophrenia, schizoaffective disorder, and bipolar disorder: Results from the Second Australian national psychosis survey. Journal of Affective Disorders. 172: 30-37. PMID 25451392 DOI: 10.1016/J.Jad.2014.09.035 |
0.411 |
|
| 2014 |
Davey CG, Chanen AM, Cotton SM, Hetrick SE, Kerr MJ, Berk M, Dean OM, Yuen K, Phelan M, Ratheesh A, Schäfer MR, Amminger GP, Parker AG, Piskulic D, Harrigan S, et al. The addition of fluoxetine to cognitive behavioural therapy for youth depression (YoDA-C): study protocol for a randomised control trial. Trials. 15: 425. PMID 25370185 DOI: 10.1186/1745-6215-15-425 |
0.435 |
|
| 2014 |
McGorry P, Keshavan M, Goldstone S, Amminger P, Allott K, Berk M, Lavoie S, Pantelis C, Yung A, Wood S, Hickie I. Biomarkers and clinical staging in psychiatry. World Psychiatry : Official Journal of the World Psychiatric Association (Wpa). 13: 211-23. PMID 25273285 DOI: 10.1002/Wps.20144 |
0.365 |
|
| 2014 |
Wang Y, Zhang H, Tang S, Liu X, O'Neil A, Turner A, Chai F, Chen F, Berk M. Assessing regional cerebral blood flow in depression using 320-slice computed tomography. Plos One. 9: e107735. PMID 25251476 DOI: 10.1371/Journal.Pone.0107735 |
0.351 |
|
| 2014 |
Thompson J, O'Donnell M, Stafford L, Nordfjaern T, Berk M. Association between attributions of responsibility for motor vehicle crashes, depressive symptoms, and return to work. Rehabilitation Psychology. 59: 376-85. PMID 25221957 DOI: 10.1037/Rep0000012 |
0.334 |
|
| 2014 |
Carvalho AF, Rocha DQ, McIntyre RS, Mesquita LM, Köhler CA, Hyphantis TN, Sales PM, Machado-Vieira R, Berk M. Adipokines as emerging depression biomarkers: a systematic review and meta-analysis. Journal of Psychiatric Research. 59: 28-37. PMID 25183029 DOI: 10.1016/J.Jpsychires.2014.08.002 |
0.389 |
|
| 2014 |
Rice SM, Hickie IB, Yung AR, Mackinnon A, Berk M, Davey C, Hermens DF, Hetrick SE, Parker AG, Schäfer MR, McGorry PD, Amminger GP. Youth depression alleviation: the Fish Oil Youth Depression Study (YoDA-F): A randomized, double-blind, placebo-controlled treatment trial. Early Intervention in Psychiatry. PMID 25130262 DOI: 10.1111/Eip.12166 |
0.405 |
|
| 2014 |
Daglas R, Conus P, Cotton SM, Macneil CA, Hasty MK, Kader L, Berk M, Hallam KT. The impact of past direct-personal traumatic events on 12-month outcome in first episode psychotic mania: trauma and early psychotic mania. The Australian and New Zealand Journal of Psychiatry. 48: 1017-24. PMID 25122448 DOI: 10.1177/0004867414545672 |
0.362 |
|
| 2014 |
Smith LT, Shelton CL, Berk M, Hasty MK, Cotton SM, Henry L, Daglas R, Gentle E, McGorry PD, Macneil CA, Conus P. The impact of insight in a first-episode mania with psychosis population on outcome at 18 months. Journal of Affective Disorders. 167: 74-9. PMID 25082117 DOI: 10.1016/J.Jad.2014.05.055 |
0.329 |
|
| 2014 |
Dodd S, Berk M, Kelin K, Zhang Q, Eriksson E, Deberdt W, Craig Nelson J. Application of the Gradient Boosted method in randomised clinical trials: Participant variables that contribute to depression treatment efficacy of duloxetine, SSRIs or placebo. Journal of Affective Disorders. 168: 284-93. PMID 25080392 DOI: 10.1016/J.Jad.2014.05.014 |
0.365 |
|
| 2014 |
Peters A, Sylvia LG, Magalhães PV, Miklowitz DJ, Frank E, Otto MW, Hansen NS, Dougherty DD, Berk M, Nierenberg AA, Deckersbach T. Age at onset, course of illness and response to psychotherapy in bipolar disorder: results from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Psychological Medicine. 44: 3455-67. PMID 25066366 DOI: 10.1017/S0033291714000804 |
0.409 |
|
| 2014 |
Bortolasci CC, Vargas HO, Souza-Nogueira A, Gastaldello Moreira E, Vargas Nunes SO, Berk M, Dodd S, Barbosa DS, Maes M. Paraoxonase (PON)1 Q192R functional genotypes and PON1 Q192R genotype by smoking interactions are risk factors for the metabolic syndrome, but not overweight or obesity. Redox Report : Communications in Free Radical Research. 19: 232-41. PMID 25037113 DOI: 10.1179/1351000214Y.0000000093 |
0.343 |
|
| 2014 |
Ghanizadeh A, Rezaee Z, Dehbozorgi S, Berk M, Akhondzadeh S. Lovastatin for the adjunctive treatment of schizophrenia: a preliminary randomized double-blind placebo-controlled trial. Psychiatry Research. 219: 431-5. PMID 25017614 DOI: 10.1016/J.Psychres.2014.06.039 |
0.335 |
|
| 2014 |
Kim SW, Berk L, Kulkarni J, Dodd S, de Castella A, Fitzgerald PB, Amminger GP, Berk M. Impact of comorbid anxiety disorders and obsessive-compulsive disorder on 24-month clinical outcomes of bipolar I disorder. Journal of Affective Disorders. 166: 243-8. PMID 25012437 DOI: 10.1016/J.Jad.2014.05.017 |
0.437 |
|
| 2014 |
Berk M, Dean OM, Cotton SM, Jeavons S, Tanious M, Kohlmann K, Hewitt K, Moss K, Allwang C, Schapkaitz I, Robbins J, Cobb H, Ng F, Dodd S, Bush AI, et al. The efficacy of adjunctive N-acetylcysteine in major depressive disorder: a double-blind, randomized, placebo-controlled trial. The Journal of Clinical Psychiatry. 75: 628-36. PMID 25004186 DOI: 10.4088/Jcp.13M08454 |
0.462 |
|
| 2014 |
Martín-Subero M, Berk L, Dodd S, Kamalesh V, Maes M, Kulkarni J, De Castella A, Fitzgerald PB, Berk M. Quality of life in bipolar and schizoaffective disorder--a naturalistic approach. Comprehensive Psychiatry. 55: 1540-5. PMID 24962450 DOI: 10.1016/J.Comppsych.2014.05.009 |
0.373 |
|
| 2014 |
Kapczinski F, Magalhães PV, Balanzá-Martinez V, Dias VV, Frangou S, Gama CS, Gonzalez-Pinto A, Grande I, Ha K, Kauer-Sant'Anna M, Kunz M, Kupka R, Leboyer M, Lopez-Jaramillo C, Post RM, ... ... Berk M, et al. Staging systems in bipolar disorder: an International Society for Bipolar Disorders Task Force Report. Acta Psychiatrica Scandinavica. 130: 354-63. PMID 24961757 DOI: 10.1111/Acps.12305 |
0.378 |
|
| 2014 |
Bauer M, Glenn T, Alda M, Andreassen OA, Angelopoulos E, Ardau R, Baethge C, Bauer R, Bellivier F, Belmaker RH, Berk M, Bjella TD, Bossini L, Bersudsky Y, Cheung EY, et al. Relationship between sunlight and the age of onset of bipolar disorder: an international multisite study. Journal of Affective Disorders. 167: 104-11. PMID 24953482 DOI: 10.1016/J.Jad.2014.05.032 |
0.365 |
|
| 2014 |
Jacka FN, Sacks G, Berk M, Allender S. Food policies for physical and mental health. Bmc Psychiatry. 14: 132. PMID 24884515 DOI: 10.1186/1471-244X-14-132 |
0.323 |
|
| 2014 |
Malhi GS, Berk M. Diagnosing bipolar disorder: Defining thresholds and setting boundaries. The Australian and New Zealand Journal of Psychiatry. 48: 500-504. PMID 24875168 DOI: 10.1177/0004867414536670 |
0.347 |
|
| 2014 |
Berk M, Berk L, Denton T. Psychiatric disorders in primary care. The Australian and New Zealand Journal of Psychiatry. 48: 497-499. PMID 24875167 DOI: 10.1177/0004867414536668 |
0.331 |
|
| 2014 |
Moylan S, Berk M, Dean OM, Samuni Y, Williams LJ, O'Neil A, Hayley AC, Pasco JA, Anderson G, Jacka FN, Maes M. Oxidative & nitrosative stress in depression: why so much stress? Neuroscience and Biobehavioral Reviews. 45: 46-62. PMID 24858007 DOI: 10.1016/J.Neubiorev.2014.05.007 |
0.361 |
|
| 2014 |
Carvalho AF, McIntyre RS, Dimelis D, Gonda X, Berk M, Nunes-Neto PR, Cha DS, Hyphantis TN, Angst J, Fountoulakis KN. Predominant polarity as a course specifier for bipolar disorder: a systematic review. Journal of Affective Disorders. 163: 56-64. PMID 24836088 DOI: 10.1016/J.Jad.2014.03.035 |
0.39 |
|
| 2014 |
Bechdolf A, Ratheesh A, Cotton SM, Nelson B, Chanen AM, Betts J, Bingmann T, Yung AR, Berk M, McGorry PD. The predictive validity of bipolar at-risk (prodromal) criteria in help-seeking adolescents and young adults: a prospective study. Bipolar Disorders. 16: 493-504. PMID 24797824 DOI: 10.1111/Bdi.12205 |
0.434 |
|
| 2014 |
Walker AJ, Kim Y, Price JB, Kale RP, McGillivray JA, Berk M, Tye SJ. Stress, Inflammation, and Cellular Vulnerability during Early Stages of Affective Disorders: Biomarker Strategies and Opportunities for Prevention and Intervention. Frontiers in Psychiatry. 5: 34. PMID 24782789 DOI: 10.3389/Fpsyt.2014.00034 |
0.393 |
|
| 2014 |
Singh AB, Bousman CA, Ng CH, Byron K, Berk M. Psychomotor Depressive Symptoms May Differentially Respond To Venlafaxine, But Norepinephrine Transporter Polymorphisms Do Not Appear Associated With Differential Ssri To Snri Efficacy In Major Depression Australian and New Zealand Journal of Psychiatry. 48: 124-125. PMID 24760384 DOI: 10.1177/0004867414529061 |
0.365 |
|
| 2014 |
Sarris J, O'Neil A, Coulson CE, Schweitzer I, Berk M. Lifestyle medicine for depression. Bmc Psychiatry. 14: 107. PMID 24721040 DOI: 10.1186/1471-244X-14-107 |
0.393 |
|
| 2014 |
Kulkarni J, Berk M, Wang W, Mu L, Scarr E, Van Rheenen TE, Worsley R, Gurvich C, Gavrilidis E, de Castella A, Fitzgerald P, Davis SR. A four week randomised control trial of adjunctive medroxyprogesterone and tamoxifen in women with mania. Psychoneuroendocrinology. 43: 52-61. PMID 24703170 DOI: 10.1016/J.Psyneuen.2014.02.004 |
0.331 |
|
| 2014 |
Bortolasci CC, Vargas HO, Souza-Nogueira A, Barbosa DS, Moreira EG, Nunes SO, Berk M, Dodd S, Maes M. Lowered plasma paraoxonase (PON)1 activity is a trait marker of major depression and PON1 Q192R gene polymorphism-smoking interactions differentially predict the odds of major depression and bipolar disorder. Journal of Affective Disorders. 159: 23-30. PMID 24679385 DOI: 10.1016/J.Jad.2014.02.018 |
0.429 |
|
| 2014 |
Asevedo E, Mendes AC, Berk M, Brietzke E. Systematic review of N-acetylcysteine in the treatment of addictions. Revista Brasileira De Psiquiatria (Sã£O Paulo, Brazil : 1999). 36: 168-75. PMID 24676047 DOI: 10.1590/1516-4446-2013-1244 |
0.319 |
|
| 2014 |
Odebrecht Vargas Nunes S, Pizzo de Castro MR, Ehara Watanabe MA, Losi Guembarovski R, Odebrecht Vargas H, Reiche EM, Kaminami Morimoto H, Dodd S, Berk M. Genetic polymorphisms in glutathione-S-transferases are associated with anxiety and mood disorders in nicotine dependence. Psychiatric Genetics. 24: 87-93. PMID 24637631 DOI: 10.1097/Ypg.0000000000000023 |
0.351 |
|
| 2014 |
O'Neil A, Berk M, Venugopal K, Kim SW, Williams LJ, Jacka FN. The association between poor dental health and depression: findings from a large-scale, population-based study (the NHANES study). General Hospital Psychiatry. 36: 266-70. PMID 24636212 DOI: 10.1016/J.Genhosppsych.2014.01.009 |
0.347 |
|
| 2014 |
Malhi GS, Bargh DM, Coulston CM, Das P, Berk M. Predicting bipolar disorder on the basis of phenomenology: implications for prevention and early intervention. Bipolar Disorders. 16: 455-70. PMID 24636153 DOI: 10.1111/Bdi.12133 |
0.417 |
|
| 2014 |
Vargas HO, Nunes SO, Barbosa DS, Vargas MM, Cestari A, Dodd S, Venugopal K, Maes M, Berk M. Castelli risk indexes 1 and 2 are higher in major depression but other characteristics of the metabolic syndrome are not specific to mood disorders. Life Sciences. 102: 65-71. PMID 24607777 DOI: 10.1016/J.Lfs.2014.02.033 |
0.389 |
|
| 2014 |
Maes M, Anderson G, Kubera M, Berk M. Targeting classical IL-6 signalling or IL-6 trans-signalling in depression? Expert Opinion On Therapeutic Targets. 18: 495-512. PMID 24548241 DOI: 10.1517/14728222.2014.888417 |
0.316 |
|
| 2014 |
Stange JP, Sylvia LG, da Silva Magalhães PV, Miklowitz DJ, Otto MW, Frank E, Berk M, Hansen NS, Dougherty DD, Nierenberg AA, Deckersbach T. Extreme attributions predict suicidal ideation and suicide attempts in bipolar disorder: prospective data from STEP-BD. World Psychiatry : Official Journal of the World Psychiatric Association (Wpa). 13: 95-6. PMID 24497260 DOI: 10.1002/Wps.20093 |
0.406 |
|
| 2014 |
Stuart AL, Pasco JA, Jacka FN, Brennan SL, Berk M, Williams LJ. Comparison of self-report and structured clinical interview in the identification of depression. Comprehensive Psychiatry. 55: 866-9. PMID 24467941 DOI: 10.1016/J.Comppsych.2013.12.019 |
0.352 |
|
| 2014 |
Carvalho AF, Berk M, Hyphantis TN, McIntyre RS. The integrative management of treatment-resistant depression: a comprehensive review and perspectives. Psychotherapy and Psychosomatics. 83: 70-88. PMID 24458008 DOI: 10.1159/000357500 |
0.419 |
|
| 2014 |
Jacka FN, Berk M. Prevention of schizophrenia--will a broader prevention agenda support this aim? Schizophrenia Bulletin. 40: 237-9. PMID 24391020 DOI: 10.1093/Schbul/Sbt202 |
0.329 |
|
| 2014 |
Sanna L, Stuart AL, Pasco JA, Jacka FN, Berk M, Maes M, O'Neil A, Girardi P, Williams LJ. Atopic disorders and depression: findings from a large, population-based study. Journal of Affective Disorders. 155: 261-5. PMID 24308896 DOI: 10.1016/J.Jad.2013.11.009 |
0.447 |
|
| 2014 |
Sanna L, Stuart AL, Pasco JA, Kotowicz MA, Berk M, Girardi P, Williams LJ. Suicidal ideation and physical illness: does the link lie with depression? Journal of Affective Disorders. 152: 422-6. PMID 24268594 DOI: 10.1016/J.Jad.2013.10.008 |
0.376 |
|
| 2014 |
Anderson G, Berk M, Dean O, Moylan S, Maes M. Role of immune-inflammatory and oxidative and nitrosative stress pathways in the etiology of depression: therapeutic implications. Cns Drugs. 28: 1-10. PMID 24150993 DOI: 10.1007/S40263-013-0119-1 |
0.393 |
|
| 2014 |
Deckersbach T, Peters AT, Sylvia L, Urdahl A, Magalhães PV, Otto MW, Frank E, Miklowitz DJ, Berk M, Kinrys G, Nierenberg A. Do comorbid anxiety disorders moderate the effects of psychotherapy for bipolar disorder? Results from STEP-BD. The American Journal of Psychiatry. 171: 178-86. PMID 24077657 DOI: 10.1176/Appi.Ajp.2013.13020225 |
0.439 |
|
| 2014 |
Anderson G, Berk M, Maes M. Biological phenotypes underpin the physio-somatic symptoms of somatization, depression, and chronic fatigue syndrome. Acta Psychiatrica Scandinavica. 129: 83-97. PMID 23952563 DOI: 10.1111/Acps.12182 |
0.352 |
|
| 2014 |
Ghanizadeh A, Sahraeizadeh A, Berk M. A head-to-head comparison of aripiprazole and risperidone for safety and treating autistic disorders, a randomized double blind clinical trial. Child Psychiatry and Human Development. 45: 185-92. PMID 23801256 DOI: 10.1007/S10578-013-0390-X |
0.354 |
|
| 2014 |
Berk M, Berk L, Dodd S, Cotton S, Macneil C, Daglas R, Conus P, Bechdolf A, Moylan S, Malhi GS. Stage managing bipolar disorder. Bipolar Disorders. 16: 471-7. PMID 23782499 DOI: 10.1111/Bdi.12099 |
0.363 |
|
| 2014 |
Singh AB, Nierenberg AA, Yatham LN, Berk M. Atypical antipsychotic agents; Peas in a pod or chalk and cheese? Bmc Medicine. 12. DOI: 10.1186/S12916-014-0126-1 |
0.3 |
|
| 2014 |
Nguyen T, Phung D, Dao B, Venkatesh S, Berk M. Affective and content analysis of online depression communities Ieee Transactions On Affective Computing. 5: 217-226. DOI: 10.1109/Taffc.2014.2315623 |
0.313 |
|
| 2014 |
Martin-Subero M, Odebrecht H, Odebrecht S, Sabbatini D, Rossi P, Dodd S, Berk M, Maes M. P.1.f.012 Major depression and bipolar disorder contribute significantly towards an increased atherogenic index of plasma European Neuropsychopharmacology. 24. DOI: 10.1016/S0924-977X(14)70311-6 |
0.398 |
|
| 2014 |
Giorlando F, Markanday S, Anderson A, Carpenter R, Berk M. Temporal order assessment in patients with bipolar disorder Procedia - Social and Behavioral Sciences. 126: 216-216. DOI: 10.1016/J.Sbspro.2014.02.381 |
0.761 |
|
| 2014 |
Coulson CE, Williams LJ, Berk M, Lubman DI, Quirk SE, Pasco JA. Association between alcohol consumption and self-reported depression among elderly Australian men Geriatric Mental Health Care. 2: 3-8. DOI: 10.1016/J.Gmhc.2014.09.001 |
0.332 |
|
| 2013 |
Young AH, Calabrese JR, Gustafsson U, Berk M, McElroy SL, Thase ME, Suppes T, Earley W. Quetiapine monotherapy in bipolar II depression: combined data from four large, randomized studies. International Journal of Bipolar Disorders. 1: 10. PMID 25505677 DOI: 10.1186/2194-7511-1-10 |
0.38 |
|
| 2013 |
Castle DJ, Piterman L, Berk M. Difficult-to-treat depression. The Medical Journal of Australia. 199: S4-5. PMID 25370285 DOI: 10.5694/mja12.10761 |
0.359 |
|
| 2013 |
Berk M, Berk L, Davey CG, Moylan S, Giorlando F, Singh AB, Kalra H, Dodd S, Malhi GS. Treatment of bipolar depression. The Medical Journal of Australia. 199: S32-5. PMID 25370283 DOI: 10.5694/mja12.10611 |
0.776 |
|
| 2013 |
Jacka FN, Berk M. Depression, diet and exercise. The Medical Journal of Australia. 199: S21-3. PMID 25370279 DOI: 10.5694/Mja12.10508 |
0.376 |
|
| 2013 |
Anderson G, Kubera M, Duda W, Lasoń W, Berk M, Maes M. Increased IL-6 trans-signaling in depression: focus on the tryptophan catabolite pathway, melatonin and neuroprogression. Pharmacological Reports : Pr. 65: 1647-54. PMID 24553013 DOI: 10.1016/S1734-1140(13)71526-3 |
0.305 |
|
| 2013 |
Singh AB, Bousman CA, Ng CH, Berk M. High impact child abuse may predict risk of elevated suicidality during antidepressant initiation. The Australian and New Zealand Journal of Psychiatry. 47: 1191-5. PMID 24280998 DOI: 10.1177/0004867413510212 |
0.351 |
|
| 2013 |
Nemeroff CB, Weinberger D, Rutter M, MacMillan HL, Bryant RA, Wessely S, Stein DJ, Pariante CM, Seemüller F, Berk M, Malhi GS, Preisig M, Brüne M, Lysaker P. DSM-5: a collection of psychiatrist views on the changes, controversies, and future directions. Bmc Medicine. 11: 202. PMID 24229007 DOI: 10.1186/1741-7015-11-202 |
0.424 |
|
| 2013 |
Berk M, Williams LJ, Jacka FN, O'Neil A, Pasco JA, Moylan S, Allen NB, Stuart AL, Hayley AC, Byrne ML, Maes M. So depression is an inflammatory disease, but where does the inflammation come from? Bmc Medicine. 11: 200. PMID 24228900 DOI: 10.1186/1741-7015-11-200 |
0.413 |
|
| 2013 |
Pacchiarotti I, Bond DJ, Baldessarini RJ, Nolen WA, Grunze H, Licht RW, Post RM, Berk M, Goodwin GM, Sachs GS, Tondo L, Findling RL, Youngstrom EA, Tohen M, Undurraga J, et al. The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders. The American Journal of Psychiatry. 170: 1249-62. PMID 24030475 DOI: 10.1176/Appi.Ajp.2013.13020185 |
0.415 |
|
| 2013 |
Berk M, Scott J, Macmillan I, Callaly T, Christensen HM. The need for specialist services for serious and recurrent mood disorders. The Australian and New Zealand Journal of Psychiatry. 47: 815-8. PMID 23985792 DOI: 10.1177/0004867413479407 |
0.328 |
|
| 2013 |
Sanna L, Stuart AL, Berk M, Pasco JA, Girardi P, Williams LJ. Gastro oesophageal reflux disease (GORD)-related symptoms and its association with mood and anxiety disorders and psychological symptomology: a population-based study in women. Bmc Psychiatry. 13: 194. PMID 23883104 DOI: 10.1186/1471-244X-13-194 |
0.386 |
|
| 2013 |
Vargas HO, Nunes SO, Pizzo de Castro M, Bortolasci CC, Sabbatini Barbosa D, Kaminami Morimoto H, Venugopal K, Dodd S, Maes M, Berk M. Oxidative stress and lowered total antioxidant status are associated with a history of suicide attempts. Journal of Affective Disorders. 150: 923-30. PMID 23856278 DOI: 10.1016/J.Jad.2013.05.016 |
0.339 |
|
| 2013 |
Berk L, Berk M, Dodd S, Kelly C, Cvetkovski S, Jorm AF. Evaluation of the acceptability and usefulness of an information website for caregivers of people with bipolar disorder. Bmc Medicine. 11: 162. PMID 23844755 DOI: 10.1186/1741-7015-11-162 |
0.397 |
|
| 2013 |
Wang Y, Zhao X, O'Neil A, Turner A, Liu X, Berk M. Altered cardiac autonomic nervous function in depression. Bmc Psychiatry. 13: 187. PMID 23842138 DOI: 10.1186/1471-244X-13-187 |
0.333 |
|
| 2013 |
Giorlando F, Teister J, Dodd S, Udina M, Berk M. Hyponatraemia: an audit of aged psychiatry patients taking SSRIs and SNRIs. Current Drug Safety. 8: 175-80. PMID 23841535 DOI: 10.2174/15748863113089990036 |
0.759 |
|
| 2013 |
Nordfjærn T, Bjerkeset O, Moylan S, Berk M, Gråwe RW. Clusters of personality traits and psychological symptoms associated with later benzodiazepine prescriptions in the general population: The HUNT Cohort Study. Addictive Behaviors. 38: 2575-80. PMID 23811061 DOI: 10.1016/J.Addbeh.2013.06.010 |
0.331 |
|
| 2013 |
Quirk SE, Williams LJ, O'Neil A, Pasco JA, Jacka FN, Housden S, Berk M, Brennan SL. The association between diet quality, dietary patterns and depression in adults: a systematic review. Bmc Psychiatry. 13: 175. PMID 23802679 DOI: 10.1186/1471-244X-13-175 |
0.352 |
|
| 2013 |
Jacka FN, Reavley NJ, Jorm AF, Toumbourou JW, Lewis AJ, Berk M. Prevention of common mental disorders: what can we learn from those who have gone before and where do we go next? The Australian and New Zealand Journal of Psychiatry. 47: 920-9. PMID 23798717 DOI: 10.1177/0004867413493523 |
0.404 |
|
| 2013 |
Stange JP, Sylvia LG, Magalhães PV, Frank E, Otto MW, Miklowitz DJ, Berk M, Nierenberg AA, Deckersbach T. Extreme attributions predict transition from depression to mania or hypomania in bipolar disorder. Journal of Psychiatric Research. 47: 1329-36. PMID 23791456 DOI: 10.1016/J.Jpsychires.2013.05.016 |
0.469 |
|
| 2013 |
Moylan S, Jacka FN, Pasco JA, Berk M. How cigarette smoking may increase the risk of anxiety symptoms and anxiety disorders: a critical review of biological pathways. Brain and Behavior. 3: 302-26. PMID 23785661 DOI: 10.1002/Brb3.137 |
0.318 |
|
| 2013 |
Morris G, Anderson G, Berk M, Maes M. Coenzyme Q10 depletion in medical and neuropsychiatric disorders: potential repercussions and therapeutic implications. Molecular Neurobiology. 48: 883-903. PMID 23761046 DOI: 10.1007/S12035-013-8477-8 |
0.346 |
|
| 2013 |
Ghanizadeh A, Berk M. Molecular hydrogen: an overview of its neurobiological effects and therapeutic potential for bipolar disorder and schizophrenia. Medical Gas Research. 3: 11. PMID 23742229 DOI: 10.1186/2045-9912-3-11 |
0.39 |
|
| 2013 |
McIntyre RS, Tohen M, Berk M, Zhao J, Weiller E. DSM-5 mixed specifier for manic episodes: evaluating the effect of depressive features on severity and treatment outcome using asenapine clinical trial data. Journal of Affective Disorders. 150: 378-83. PMID 23712026 DOI: 10.1016/J.Jad.2013.04.025 |
0.395 |
|
| 2013 |
Dodd S, Berk M, Kelin K, Mancini M, Schacht A. Treatment response for acute depression is not associated with number of previous episodes: lack of evidence for a clinical staging model for major depressive disorder. Journal of Affective Disorders. 150: 344-9. PMID 23683993 DOI: 10.1016/J.Jad.2013.04.016 |
0.438 |
|
| 2013 |
Hayley AC, Williams LJ, Berk M, Kennedy GA, Jacka FN, Pasco JA. The relationship between excessive daytime sleepiness and depressive and anxiety disorders in women. The Australian and New Zealand Journal of Psychiatry. 47: 772-8. PMID 23677847 DOI: 10.1177/0004867413490036 |
0.41 |
|
| 2013 |
Berk M. The DSM-5: Hyperbole, Hope or Hypothesis? Bmc Medicine. 11: 128. PMID 23672603 DOI: 10.1186/1741-7015-11-128 |
0.313 |
|
| 2013 |
Subero MM, Berk L, Dodd S, Kulkarni J, De Castella A, Fitzgerald PB, Berk M. To a broader concept of remission: rating the health-related quality of life in bipolar disorder. Journal of Affective Disorders. 150: 673-6. PMID 23664566 DOI: 10.1016/J.Jad.2013.03.023 |
0.348 |
|
| 2013 |
Nunes SO, Vargas HO, Prado E, Barbosa DS, de Melo LP, Moylan S, Dodd S, Berk M. The shared role of oxidative stress and inflammation in major depressive disorder and nicotine dependence. Neuroscience and Biobehavioral Reviews. 37: 1336-45. PMID 23660457 DOI: 10.1016/J.Neubiorev.2013.04.014 |
0.393 |
|
| 2013 |
Ghanizadeh A, Derakhshan N, Berk M. N-acetylcysteine versus placebo for treating nail biting, a double blind randomized placebo controlled clinical trial. Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry. 12: 223-8. PMID 23651231 DOI: 10.2174/1871523011312030003 |
0.302 |
|
| 2013 |
Samuni Y, Goldstein S, Dean OM, Berk M. The chemistry and biological activities of N-acetylcysteine. Biochimica Et Biophysica Acta. 1830: 4117-29. PMID 23618697 DOI: 10.1016/J.Bbagen.2013.04.016 |
0.3 |
|
| 2013 |
Sanna L, Stuart AL, Pasco JA, Kotowicz MA, Berk M, Girardi P, Brennan SL, Williams LJ. Physical comorbidities in men with mood and anxiety disorders: a population-based study. Bmc Medicine. 11: 110. PMID 23618390 DOI: 10.1186/1741-7015-11-110 |
0.387 |
|
| 2013 |
O'Neil A, Berk M, Itsiopoulos C, Castle D, Opie R, Pizzinga J, Brazionis L, Hodge A, Mihalopoulos C, Chatterton ML, Dean OM, Jacka FN. A randomised, controlled trial of a dietary intervention for adults with major depression (the "SMILES" trial): study protocol. Bmc Psychiatry. 13: 114. PMID 23587364 DOI: 10.1186/1471-244X-13-114 |
0.409 |
|
| 2013 |
Berk M, Sarris J, Coulson CE, Jacka FN. Lifestyle management of unipolar depression. Acta Psychiatrica Scandinavica. Supplementum. 38-54. PMID 23586875 DOI: 10.1111/Acps.12124 |
0.367 |
|
| 2013 |
Malhi GS, Hitching R, Berk M, Boyce P, Porter R, Fritz K. Pharmacological management of unipolar depression. Acta Psychiatrica Scandinavica. Supplementum. 6-23. PMID 23586873 DOI: 10.1111/Acps.12122 |
0.391 |
|
| 2013 |
Vargas HO, Nunes SO, de Castro MR, Vargas MM, Barbosa DS, Bortolasci CC, Venugopal K, Dodd S, Berk M. Oxidative stress and inflammatory markers are associated with depression and nicotine dependence. Neuroscience Letters. 544: 136-40. PMID 23583694 DOI: 10.1016/J.Neulet.2013.03.059 |
0.395 |
|
| 2013 |
Nelson JC, Zhang Q, Kelin K, Eriksson E, Deberdt W, Berk M. Baseline patient characteristics associated with placebo remission and their impact on remission with duloxetine and selected SSRI antidepressants. Current Medical Research and Opinion. 29: 827-33. PMID 23581532 DOI: 10.1185/03007995.2013.795140 |
0.401 |
|
| 2013 |
Berk M, Berk L. Is 'depression' the new 'neurosis'? The Australian and New Zealand Journal of Psychiatry. 47: 297-8. PMID 23568154 DOI: 10.1177/0004867413482495 |
0.347 |
|
| 2013 |
Stange JP, Sylvia LG, da Silva Magalhães PV, Miklowitz DJ, Otto MW, Frank E, Berk M, Nierenberg AA, Deckersbach T. Extreme attributions predict the course of bipolar depression: results from the STEP-BD randomized controlled trial of psychosocial treatment. The Journal of Clinical Psychiatry. 74: 249-55. PMID 23561230 DOI: 10.4088/Jcp.12M08019 |
0.436 |
|
| 2013 |
Scott J, Leboyer M, Hickie I, Berk M, Kapczinski F, Frank E, Kupfer D, McGorry P. Clinical staging in psychiatry: a cross-cutting model of diagnosis with heuristic and practical value. The British Journal of Psychiatry : the Journal of Mental Science. 202: 243-5. PMID 23549937 DOI: 10.1192/Bjp.Bp.112.110858 |
0.335 |
|
| 2013 |
Cotton SM, Lambert M, Schimmelmann BG, Mackinnon A, Gleeson JF, Berk M, Hides L, Chanen AM, Scott J, Schöttle D, McGorry PD, Conus P. Differences between first episode schizophrenia and schizoaffective disorder. Schizophrenia Research. 147: 169-74. PMID 23528796 DOI: 10.1016/J.Schres.2013.02.036 |
0.395 |
|
| 2013 |
Berk M, Dean O, Drexhage H, McNeil JJ, Moylan S, O'Neil A, Davey CG, Sanna L, Maes M. Aspirin: a review of its neurobiological properties and therapeutic potential for mental illness. Bmc Medicine. 11: 74. PMID 23506529 DOI: 10.1186/1741-7015-11-74 |
0.385 |
|
| 2013 |
Cotton SM, Lambert M, Berk M, Schimmelmann BG, Butselaar FJ, McGorry PD, Conus P. Gender differences in first episode psychotic mania. Bmc Psychiatry. 13: 82. PMID 23497439 DOI: 10.1186/1471-244X-13-82 |
0.304 |
|
| 2013 |
Magalhães PV, Dean OM, Bush AI, Copolov DL, Malhi GS, Kohlmann K, Jeavons S, Schapkaitz I, Anderson-Hunt M, Berk M. A preliminary investigation on the efficacy of N-acetyl cysteine for mania or hypomania. The Australian and New Zealand Journal of Psychiatry. 47: 564-8. PMID 23493756 DOI: 10.1177/0004867413481631 |
0.367 |
|
| 2013 |
Singh AB, Bousman CA, Ng CH, Byron K, Berk M. Psychomotor depressive symptoms may differentially respond to venlafaxine. International Clinical Psychopharmacology. 28: 121-6. PMID 23442739 DOI: 10.1097/Yic.0B013E32835F1B9F |
0.406 |
|
| 2013 |
Berk M, Dodd S, Berk L. Treatment of bipolar depression. The Medical Journal of Australia. 198: 139. PMID 23418688 DOI: 10.5694/Mja12.11740 |
0.442 |
|
| 2013 |
Moylan S, Eyre HA, Maes M, Baune BT, Jacka FN, Berk M. Exercising the worry away: how inflammation, oxidative and nitrogen stress mediates the beneficial effect of physical activity on anxiety disorder symptoms and behaviours. Neuroscience and Biobehavioral Reviews. 37: 573-84. PMID 23415701 DOI: 10.1016/J.Neubiorev.2013.02.003 |
0.379 |
|
| 2013 |
Frey BN, Andreazza AC, Houenou J, Jamain S, Goldstein BI, Frye MA, Leboyer M, Berk M, Malhi GS, Lopez-Jaramillo C, Taylor VH, Dodd S, Frangou S, Hall GB, Fernandes BS, et al. Biomarkers in bipolar disorder: a positional paper from the International Society for Bipolar Disorders Biomarkers Task Force. The Australian and New Zealand Journal of Psychiatry. 47: 321-32. PMID 23411094 DOI: 10.1177/0004867413478217 |
0.399 |
|
| 2013 |
Wang Y, Liu X, Zhang D, Chen J, Liu S, Berk M. The effects of apoptosis vulnerability markers on the myocardium in depression after myocardial infarction. Bmc Medicine. 11: 32. PMID 23394076 DOI: 10.1186/1741-7015-11-32 |
0.355 |
|
| 2013 |
Malhi GS, Tanious M, Das P, Coulston CM, Berk M. Potential mechanisms of action of lithium in bipolar disorder. Current understanding. Cns Drugs. 27: 135-53. PMID 23371914 DOI: 10.1007/S40263-013-0039-0 |
0.392 |
|
| 2013 |
Berk M, Malhi GS, Gray LJ, Dean OM. The promise of N-acetylcysteine in neuropsychiatry. Trends in Pharmacological Sciences. 34: 167-77. PMID 23369637 DOI: 10.1016/J.Tips.2013.01.001 |
0.42 |
|
| 2013 |
Das P, Tanious M, Fritz K, Dodd S, Dean OM, Berk M, Malhi GS. Metabolite profiles in the anterior cingulate cortex of depressed patients differentiate those taking N-acetyl-cysteine versus placebo. The Australian and New Zealand Journal of Psychiatry. 47: 347-54. PMID 23341476 DOI: 10.1177/0004867412474074 |
0.387 |
|
| 2013 |
Walker AJ, Burnett SA, Hasebe K, McGillivray JA, Gray LJ, McGee SL, Walder K, Berk M, Tye SJ. Chronic adrenocorticotrophic hormone treatment alters tricyclic antidepressant efficacy and prefrontal monoamine tissue levels. Behavioural Brain Research. 242: 76-83. PMID 23276607 DOI: 10.1016/J.Bbr.2012.12.033 |
0.315 |
|
| 2013 |
Yatham LN, Kennedy SH, Parikh SV, Schaffer A, Beaulieu S, Alda M, O'Donovan C, Macqueen G, McIntyre RS, Sharma V, Ravindran A, Young LT, Milev R, Bond DJ, Frey BN, ... ... Berk M, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013. Bipolar Disorders. 15: 1-44. PMID 23237061 DOI: 10.1111/Bdi.12025 |
0.404 |
|
| 2013 |
Dodd S, Maes M, Anderson G, Dean OM, Moylan S, Berk M. Putative neuroprotective agents in neuropsychiatric disorders. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 42: 135-45. PMID 23178231 DOI: 10.1016/J.Pnpbp.2012.11.007 |
0.411 |
|
| 2013 |
Ghanizadeh A, Berk M. Zinc for treating of children and adolescents with attention-deficit hyperactivity disorder: a systematic review of randomized controlled clinical trials. European Journal of Clinical Nutrition. 67: 122-4. PMID 23169472 DOI: 10.1038/Ejcn.2012.177 |
0.308 |
|
| 2013 |
Ghanizadeh A, Freeman RD, Berk M. Efficacy and adverse effects of venlafaxine in children and adolescents with ADHD: a systematic review of non-controlled and controlled trials. Reviews On Recent Clinical Trials. 8: 2-8. PMID 23157376 DOI: 10.2174/1574887111308010002 |
0.311 |
|
| 2013 |
Ratheesh A, Lin A, Nelson B, Wood SJ, Brewer W, Betts J, Berk M, McGorry P, Yung AR, Bechdolf A. Neurocognitive functioning in the prodrome of mania--an exploratory study. Journal of Affective Disorders. 147: 441-5. PMID 23141631 DOI: 10.1016/J.Jad.2012.09.017 |
0.347 |
|
| 2013 |
Williams LJ, Pasco JA, Jacka FN, Hodge JM, Kotowicz MA, Berk M. Quantitative Heel Ultrasound (QUS) measures of bone quality in association with mood and anxiety disorders. Journal of Affective Disorders. 146: 395-400. PMID 23122528 DOI: 10.1016/J.Jad.2012.09.025 |
0.358 |
|
| 2013 |
Data-Franco J, Berk M. The nocebo effect: a clinicians guide. The Australian and New Zealand Journal of Psychiatry. 47: 617-23. PMID 23093053 DOI: 10.1177/0004867412464717 |
0.319 |
|
| 2013 |
Jacka FN, Pasco JA, Williams LJ, Meyer BJ, Digger R, Berk M. Dietary intake of fish and PUFA, and clinical depressive and anxiety disorders in women. The British Journal of Nutrition. 109: 2059-66. PMID 23051591 DOI: 10.1017/S0007114512004102 |
0.435 |
|
| 2013 |
Anderson G, Maes M, Berk M. Schizophrenia is primed for an increased expression of depression through activation of immuno-inflammatory, oxidative and nitrosative stress, and tryptophan catabolite pathways. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 42: 101-14. PMID 22930036 DOI: 10.1016/J.Pnpbp.2012.07.016 |
0.407 |
|
| 2013 |
Maes M, Kubera M, Mihaylova I, Geffard M, Galecki P, Leunis JC, Berk M. Increased autoimmune responses against auto-epitopes modified by oxidative and nitrosative damage in depression: implications for the pathways to chronic depression and neuroprogression. Journal of Affective Disorders. 149: 23-9. PMID 22898471 DOI: 10.1016/J.Jad.2012.06.039 |
0.373 |
|
| 2013 |
Berk M, Berk L, Dodd S, Fitzgerald PB, de Castella AR, Filia S, Filia K, Brnabic AJ, Kelin K, Montgomery W, Kulkarni J, Stafford L. The sick role, illness cognitions and outcomes in bipolar disorder. Journal of Affective Disorders. 146: 146-9. PMID 22898470 DOI: 10.1016/J.Jad.2012.07.003 |
0.363 |
|
| 2013 |
Lauder S, Chester A, Castle D, Dodd S, Berk L, Klein B, Austin D, Gilbert M, Chamberlain JA, Murray G, White C, Piterman L, Berk M. Development of an online intervention for bipolar disorder. www.moodswings.net.au. Psychology, Health & Medicine. 18: 155-65. PMID 22712771 DOI: 10.1080/13548506.2012.689840 |
0.33 |
|
| 2013 |
Moylan S, Maes M, Wray NR, Berk M. The neuroprogressive nature of major depressive disorder: pathways to disease evolution and resistance, and therapeutic implications. Molecular Psychiatry. 18: 595-606. PMID 22525486 DOI: 10.1038/Mp.2012.33 |
0.45 |
|
| 2013 |
Malhi GS, Tanious M, Bargh D, Das P, Berk M. Safe and effective use of lithium Australian Prescriber. 36: 18-21. DOI: 10.18773/Austprescr.2013.008 |
0.416 |
|
| 2013 |
Nunes SOV, Castro MRPd, Vargas HO, Vargas MM, Machado RCBR, Fonseca ICB, Dodd S, Berk M. Clinical Characteristics and Smoking Cessation: An Analysis of Sex and Depressive Disorders Differences Addictive Disorders & Their Treatment. 12: 158-165. DOI: 10.1097/Adt.0B013E31827A63Ff |
0.338 |
|
| 2013 |
Rapado-Castro M, Dodd S, Dean O, On Z, Bush A, Berk M. P.1.g.025 N-Acetyl cysteine as a potential tobacco use cessation agent in bipolar disorder and schizophrenia European Neuropsychopharmacology. 23. DOI: 10.1016/S0924-977X(13)70312-2 |
0.342 |
|
| 2013 |
Bruschi A, Calo S, Camardese G, Grandinetti P, Palumbo C, Pizi G, Mandelli L, Serretti A, Berk M, Sciascio GD, Janiri L. 1244 – Bipolar depression rating scale (BDRS): psychometric characteristics of the italian validation European Psychiatry. 28: 1. DOI: 10.1016/S0924-9338(13)76318-1 |
0.393 |
|
| 2012 |
Kulkarni J, Filia S, Berk L, Filia K, Dodd S, de Castella A, Brnabic AJ, Lowry AJ, Kelin K, Montgomery W, Fitzgerald PB, Berk M. Treatment and outcomes of an Australian cohort of outpatients with bipolar I or schizoaffective disorder over twenty-four months: implications for clinical practice. Bmc Psychiatry. 12: 228. PMID 23244301 DOI: 10.1186/1471-244X-12-228 |
0.383 |
|
| 2012 |
O'Neil A, Sanna L, Redlich C, Sanderson K, Jacka F, Williams LJ, Pasco JA, Berk M. The impact of statins on psychological wellbeing: a systematic review and meta-analysis. Bmc Medicine. 10: 154. PMID 23206308 DOI: 10.1186/1741-7015-10-154 |
0.39 |
|
| 2012 |
Berk M. Pathways to new drug discovery in neuropsychiatry. Bmc Medicine. 10: 151. PMID 23194414 DOI: 10.1186/1741-7015-10-151 |
0.318 |
|
| 2012 |
Jacka FN, Mykletun A, Berk M. Moving towards a population health approach to the primary prevention of common mental disorders. Bmc Medicine. 10: 149. PMID 23186355 DOI: 10.1186/1741-7015-10-149 |
0.401 |
|
| 2012 |
Svendal G, Fasmer OB, Engeland A, Berk M, Lund A. Co-prescription of medication for bipolar disorder and diabetes mellitus: a nationwide population-based study with focus on gender differences. Bmc Medicine. 10: 148. PMID 23186328 DOI: 10.1186/1741-7015-10-148 |
0.346 |
|
| 2012 |
Khasraw M, Ashley D, Wheeler G, Berk M. Using lithium as a neuroprotective agent in patients with cancer. Bmc Medicine. 10: 131. PMID 23121766 DOI: 10.1186/1741-7015-10-131 |
0.304 |
|
| 2012 |
Berk M, Jacka F. Preventive strategies in depression: gathering evidence for risk factors and potential interventions. The British Journal of Psychiatry : the Journal of Mental Science. 201: 339-41. PMID 23118032 DOI: 10.1192/Bjp.Bp.111.107797 |
0.38 |
|
| 2012 |
Moylan S, Jacka FN, Pasco JA, Berk M. Cigarette smoking, nicotine dependence and anxiety disorders: a systematic review of population-based, epidemiological studies. Bmc Medicine. 10: 123. PMID 23083451 DOI: 10.1186/1741-7015-10-123 |
0.364 |
|
| 2012 |
Dean OM, Bush AI, Copolov DL, Kohlmann K, Jeavons S, Schapkaitz I, Anderson-Hunt M, Berk M. Effects of N-acetyl cysteine on cognitive function in bipolar disorder. Psychiatry and Clinical Neurosciences. 66: 514-7. PMID 23066769 DOI: 10.1111/J.1440-1819.2012.02392.X |
0.356 |
|
| 2012 |
Munkholm K, Vinberg M, Berk M, Kessing LV. State-related alterations of gene expression in bipolar disorder: a systematic review. Bipolar Disorders. 14: 684-96. PMID 23043691 DOI: 10.1111/Bdi.12005 |
0.347 |
|
| 2012 |
Macneil CA, Hasty MK, Conus P, Berk M. Is diagnosis enough to guide interventions in mental health? Using case formulation in clinical practice. Bmc Medicine. 10: 111. PMID 23016556 DOI: 10.1186/1741-7015-10-111 |
0.303 |
|
| 2012 |
Magalhães PV, Dodd S, Nierenberg AA, Berk M. Cumulative morbidity and prognostic staging of illness in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). The Australian and New Zealand Journal of Psychiatry. 46: 1058-67. PMID 23015748 DOI: 10.1177/0004867412460593 |
0.453 |
|
| 2012 |
Malhi GS, Tanious M, Berk M. Mania: diagnosis and treatment recommendations. Current Psychiatry Reports. 14: 676-86. PMID 22986995 DOI: 10.1007/S11920-012-0324-5 |
0.405 |
|
| 2012 |
Sarris J, Moylan S, Camfield DA, Pase MP, Mischoulon D, Berk M, Jacka FN, Schweitzer I. Complementary medicine, exercise, meditation, diet, and lifestyle modification for anxiety disorders: a review of current evidence. Evidence-Based Complementary and Alternative Medicine : Ecam. 2012: 809653. PMID 22969831 DOI: 10.1155/2012/809653 |
0.378 |
|
| 2012 |
Berk M, Dean OM, Cotton SM, Gama CS, Kapczinski F, Fernandes B, Kohlmann K, Jeavons S, Hewitt K, Moss K, Allwang C, Schapkaitz I, Cobb H, Bush AI, Dodd S, et al. Maintenance N-acetyl cysteine treatment for bipolar disorder: a double-blind randomized placebo controlled trial. Bmc Medicine. 10: 91. PMID 22891797 DOI: 10.1186/1741-7015-10-91 |
0.388 |
|
| 2012 |
Anderson G, Maes M, Berk M. Inflammation-related disorders in the tryptophan catabolite pathway in depression and somatization. Advances in Protein Chemistry and Structural Biology. 88: 27-48. PMID 22814705 DOI: 10.1016/B978-0-12-398314-5.00002-7 |
0.385 |
|
| 2012 |
Maes M, Berk M, Goehler L, Song C, Anderson G, Gałecki P, Leonard B. Depression and sickness behavior are Janus-faced responses to shared inflammatory pathways. Bmc Medicine. 10: 66. PMID 22747645 DOI: 10.1186/1741-7015-10-66 |
0.362 |
|
| 2012 |
Anderson RJ, Frye MA, Abulseoud OA, Lee KH, McGillivray JA, Berk M, Tye SJ. Deep brain stimulation for treatment-resistant depression: efficacy, safety and mechanisms of action. Neuroscience and Biobehavioral Reviews. 36: 1920-33. PMID 22721950 DOI: 10.1016/J.Neubiorev.2012.06.001 |
0.385 |
|
| 2012 |
Williams LJ, Pasco JA, Jacka FN, Dodd S, Berk M. Pain and the relationship with mood and anxiety disorders and psychological symptoms. Journal of Psychosomatic Research. 72: 452-6. PMID 22656442 DOI: 10.1016/J.Jpsychores.2012.03.001 |
0.322 |
|
| 2012 |
Bauer M, Glenn T, Alda M, Andreassen OA, Ardau R, Bellivier F, Berk M, Bjella TD, Bossini L, Del Zompo M, Dodd S, Fagiolini A, Frye MA, Gonzalez-Pinto A, Henry C, et al. Impact of sunlight on the age of onset of bipolar disorder. Bipolar Disorders. 14: 654-63. PMID 22612720 DOI: 10.1111/J.1399-5618.2012.01025.X |
0.326 |
|
| 2012 |
Dean OM, Bush AI, Berk M. Translating the Rosetta Stone of N-acetylcysteine. Biological Psychiatry. 71: 935-6. PMID 22579303 DOI: 10.1016/J.Biopsych.2012.04.001 |
0.406 |
|
| 2012 |
Markanday S, Data-Franco J, Dyson L, Murrant S, Arbuckle C, McGillvray J, Berk M. Acceptance and commitment therapy for treatment-resistant depression. The Australian and New Zealand Journal of Psychiatry. 46: 1198-9. PMID 22563038 DOI: 10.1177/0004867412446491 |
0.335 |
|
| 2012 |
Svendal G, Berk M, Pasco JA, Jacka FN, Lund A, Williams LJ. The use of hormonal contraceptive agents and mood disorders in women. Journal of Affective Disorders. 140: 92-6. PMID 22537684 DOI: 10.1016/J.Jad.2012.03.030 |
0.383 |
|
| 2012 |
Malhi GS, Bargh DM, McIntyre R, Gitlin M, Frye MA, Bauer M, Berk M. Balanced efficacy, safety, and tolerability recommendations for the clinical management of bipolar disorder. Bipolar Disorders. 14: 1-21. PMID 22510033 DOI: 10.1111/J.1399-5618.2012.00989.X |
0.404 |
|
| 2012 |
Pasco JA, Jacka FN, Williams LJ, Evans-Cleverdon M, Brennan SL, Kotowicz MA, Nicholson GC, Ball MJ, Berk M. Dietary selenium and major depression: a nested case-control study. Complementary Therapies in Medicine. 20: 119-23. PMID 22500660 DOI: 10.1016/J.Ctim.2011.12.008 |
0.394 |
|
| 2012 |
Dean OM, Data-Franco J, Giorlando F, Berk M. Minocycline: therapeutic potential in psychiatry. Cns Drugs. 26: 391-401. PMID 22486246 DOI: 10.2165/11632000-000000000-00000 |
0.785 |
|
| 2012 |
Anderson G, Maes M, Berk M. Biological underpinnings of the commonalities in depression, somatization, and Chronic Fatigue Syndrome. Medical Hypotheses. 78: 752-6. PMID 22445460 DOI: 10.1016/J.Mehy.2012.02.023 |
0.358 |
|
| 2012 |
Jacka FN, Pasco JA, Williams LJ, Mann N, Hodge A, Brazionis L, Berk M. Red meat consumption and mood and anxiety disorders. Psychotherapy and Psychosomatics. 81: 196-8. PMID 22433903 DOI: 10.1159/000334910 |
0.374 |
|
| 2012 |
Maes M, Kubera M, Leunis JC, Berk M. Increased IgA and IgM responses against gut commensals in chronic depression: further evidence for increased bacterial translocation or leaky gut. Journal of Affective Disorders. 141: 55-62. PMID 22410503 DOI: 10.1016/J.Jad.2012.02.023 |
0.369 |
|
| 2012 |
Jacka FN, Maes M, Pasco JA, Williams LJ, Berk M. Nutrient intakes and the common mental disorders in women. Journal of Affective Disorders. 141: 79-85. PMID 22397891 DOI: 10.1016/J.Jad.2012.02.018 |
0.409 |
|
| 2012 |
Moylan S, Giorlando F, Nordfjærn T, Berk M. The role of alprazolam for the treatment of panic disorder in Australia. The Australian and New Zealand Journal of Psychiatry. 46: 212-24. PMID 22391278 DOI: 10.1177/0004867411432074 |
0.761 |
|
| 2012 |
Malhi GS, Tanious M, Das P, Berk M. The science and practice of lithium therapy. The Australian and New Zealand Journal of Psychiatry. 46: 192-211. PMID 22391277 DOI: 10.1177/0004867412437346 |
0.348 |
|
| 2012 |
Berk M, Berk L, Udina M, Moylan S, Stafford L, Hallam K, Goldstone S, McGorry PD. Palliative models of care for later stages of mental disorder: maximizing recovery, maintaining hope, and building morale. The Australian and New Zealand Journal of Psychiatry. 46: 92-9. PMID 22311525 DOI: 10.1177/0004867411432072 |
0.325 |
|
| 2012 |
Bechdolf A, Wood SJ, Nelson B, Velakoulis D, Yücel M, Takahashi T, Yung AR, Berk M, Wong MT, Pantelis C, McGorry PD. Amygdala and insula volumes prior to illness onset in bipolar disorder: a magnetic resonance imaging study. Psychiatry Research. 201: 34-9. PMID 22281200 DOI: 10.1016/J.Pscychresns.2011.06.010 |
0.364 |
|
| 2012 |
Maes M, Fišar Z, Medina M, Scapagnini G, Nowak G, Berk M. New drug targets in depression: inflammatory, cell-mediated immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. And new drug candidates--Nrf2 activators and GSK-3 inhibitors. Inflammopharmacology. 20: 127-50. PMID 22271002 DOI: 10.1007/S10787-011-0111-7 |
0.328 |
|
| 2012 |
Macneil CA, Hallam K, Conus P, Henry L, Kader L, Berk M. Are we missing opportunities for early intervention in bipolar disorder? Expert Review of Neurotherapeutics. 12: 5-7. PMID 22243040 DOI: 10.1586/Ern.11.174 |
0.376 |
|
| Show low-probability matches. |